pathway_name,pathway_source,num_overlapping_metabolites,overlapping_metabolites,num_all_pathway_metabolites,P_metabolites,Q_metabolites
Histidine metabolism - Homo sapiens (human),KEGG,16,C16674;C00388;C05130;C05133;C00386;C02835;C01152;C00025;C05568;C00049;C00439;C01929;C00135;C00785;C03680;C16673,47 (47),1.52e-14,6.49e-11
Arginine and proline metabolism - Homo sapiens (human),KEGG,18,C00077;C02714;C00148;C02565;C02305;C00436;C05941;C05942;C00025;C02647;C04281;C04282;C01877;C00763;C05938;C03771;C00433;C00022,78 (78),6e-13,1.28e-09
Amino acid and oligopeptide SLC transporters,Reactome,14,C00077;C00064;C00163;C00148;C00402;C00022;C00740;C00025;C00033;C00049;C00491;C00080;C03283;C00135,44 (50),2.19e-12,2.66e-09
Metabolism of amino acids and derivatives,Reactome,29,C00077;C00388;C02305;C00033;C00153;C00740;C00148;C02220;C00402;C00449;C05665;C00087;C00049;C00080;C00122;C00064;C00386;C00164;C00022;C00025;C00109;C03680;C00439;C01005;C00349;C04281;C03793;C00785;C00135,246 (285),2.49e-12,2.66e-09
Biochemical Pathways Part I,Wikipathways,39,C00077;C00074;C00388;C02305;C00763;C00449;C00429;C00418;C00178;C00188;C05942;C00979;C01888;C00049;C00491;C00475;C00232;C00122;C00064;C00065;C00163;C00148;C00164;C00022;C00258;C00025;C00109;C03680;C05938;C00439;C00263;C01005;C00222;C04281;C04282;C06002;C02220;C00785;C00135,456 (467),5.88e-12,5.02e-09
Transport of inorganic cations/anions and amino acids/oligopeptides,Reactome,14,C00077;C00064;C00163;C00148;C00402;C00022;C00740;C00025;C00033;C00049;C00491;C00080;C03283;C00135,50 (56),1.56e-11,1.11e-08
Histidine metabolism,EHMN,13,C05665;C00222;C05130;C00033;C00386;C02835;C00025;C03680;C00388;C00080;C00785;C00439;C00135,45 (45),5.62e-11,3.43e-08
Protein digestion and absorption - Homo sapiens (human),KEGG,12,C00064;C00065;C00163;C00148;C00388;C00188;C00033;C00025;C00049;C00491;C00080;C00135,47 (47),1.58e-09,8.43e-07
Urea cycle and metabolism of arginine_ proline_ glutamate_ aspartate and asparagine,EHMN,18,C02714;C00065;C00148;C04281;C00033;C00022;C00025;C00109;C01879;C00402;C04282;C00049;C05938;C00080;C00232;C00064;C00077;C00122,125 (125),2.43e-09,9.56e-07
Histidine Metabolism,SMPDB,11,C00388;C00025;C00386;C02835;C01152;C03680;C00080;C00135;C00785;C00439;C05130,39 (40),2.46e-09,9.56e-07
Histidinemia,SMPDB,11,C00388;C00025;C00386;C02835;C01152;C03680;C00080;C00135;C00785;C00439;C05130,39 (40),2.46e-09,9.56e-07
Histidine_ lysine_ phenylalanine_ tyrosine_ proline and tryptophan catabolism,Reactome,15,C00148;C00388;C00022;C00386;C00025;C03680;C00164;C00049;C02220;C00080;C00449;C00135;C00785;C00439;C00122,85 (91),3.31e-09,1.13e-06
Glycine_ serine and threonine metabolism - Homo sapiens (human),KEGG,12,C00065;C05519;C00263;C00188;C00022;C00258;C01005;C00740;C00109;C01888;C00049;C03283,50 (50),3.43e-09,1.13e-06
Amino Acid metabolism,Wikipathways,16,C00064;C00065;C00148;C05130;C02305;C00188;C00077;C00025;C00109;C00388;C00074;C00049;C00349;C00135;C00022;C00122,105 (108),8.85e-09,2.7e-06
<i>S</i>-methyl-5-thio-&alpha;-D-ribose 1-phosphate degradation,HumanCyc,10,C00064;C00065;C00148;C00188;C00022;C00025;C00109;C00049;C00080;C00135,35 (35),1.19e-08,3.39e-06
Amino acid transport across the plasma membrane,Reactome,9,C00077;C00064;C00148;C00740;C00025;C00491;C00080;C03283;C00135,29 (32),2.97e-08,7.46e-06
&gamma;-glutamyl cycle,HumanCyc,9,C00064;C00065;C00148;C00188;C00025;C00049;C00080;C01879;C00135,29 (29),2.97e-08,7.46e-06
Glycine_ serine_ alanine and threonine metabolism,EHMN,14,C00077;C00065;C05519;C02305;C00188;C00033;C00022;C00258;C01005;C00025;C01888;C00937;C00080;C00064,88 (88),4.62e-08,9.15e-06
Histidine catabolism,Reactome,8,C00388;C00386;C00025;C03680;C00080;C00785;C00439;C00135,23 (23),6.6e-08,9.15e-06
Prolinemia Type II,SMPDB,11,C00077;C00148;C02305;C00025;C04281;C04282;C00049;C00763;C05938;C00080;C00122,52 (52),6.64e-08,9.15e-06
Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),SMPDB,11,C00077;C00148;C02305;C00025;C04281;C04282;C00049;C00763;C05938;C00080;C00122,52 (52),6.64e-08,9.15e-06
Hyperornithinemia with gyrate atrophy (HOGA),SMPDB,11,C00077;C00148;C02305;C00025;C04281;C04282;C00049;C00763;C05938;C00080;C00122,52 (52),6.64e-08,9.15e-06
Creatine deficiency_ guanidinoacetate methyltransferase deficiency,SMPDB,11,C00077;C00148;C02305;C00025;C04281;C04282;C00049;C00763;C05938;C00080;C00122,52 (52),6.64e-08,9.15e-06
L-arginine:glycine amidinotransferase deficiency,SMPDB,11,C00077;C00148;C02305;C00025;C04281;C04282;C00049;C00763;C05938;C00080;C00122,52 (52),6.64e-08,9.15e-06
Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],SMPDB,11,C00077;C00148;C02305;C00025;C04281;C04282;C00049;C00763;C05938;C00080;C00122,52 (52),6.64e-08,9.15e-06
Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),SMPDB,11,C00077;C00148;C02305;C00025;C04281;C04282;C00049;C00763;C05938;C00080;C00122,52 (52),6.64e-08,9.15e-06
Prolidase Deficiency (PD),SMPDB,11,C00077;C00148;C02305;C00025;C04281;C04282;C00049;C00763;C05938;C00080;C00122,52 (52),6.64e-08,9.15e-06
Arginine and Proline Metabolism,SMPDB,11,C00077;C00148;C02305;C00025;C04281;C04282;C00049;C00763;C05938;C00080;C00122,52 (52),6.64e-08,9.15e-06
Hyperprolinemia Type I,SMPDB,11,C00077;C00148;C02305;C00025;C04281;C04282;C00049;C00763;C05938;C00080;C00122,52 (52),6.64e-08,9.15e-06
Hyperprolinemia Type II,SMPDB,11,C00077;C00148;C02305;C00025;C04281;C04282;C00049;C00763;C05938;C00080;C00122,52 (52),6.64e-08,9.15e-06
Ornithine Aminotransferase Deficiency (OAT Deficiency),SMPDB,11,C00077;C00148;C02305;C00025;C04281;C04282;C00049;C00763;C05938;C00080;C00122,52 (52),6.64e-08,9.15e-06
SLC-mediated transmembrane transport,Reactome,18,C00077;C00064;C00163;C00148;C00388;C00178;C00033;C00022;C00740;C00025;C00402;C00049;C00491;C00080;C03283;C00135;C00475;C00164,155 (166),7.86e-08,1.05e-05
tRNA charging,HumanCyc,8,C00064;C00065;C00148;C00188;C00025;C00049;C00080;C00135,24 (24),9.68e-08,1.21e-05
Carnosinuria_ carnosinemia,SMPDB,9,C05665;C00386;C01152;C00025;C00222;C00049;C00080;C00429;C00135,33 (34),1.05e-07,1.21e-05
Ureidopropionase deficiency,SMPDB,9,C05665;C00386;C01152;C00025;C00222;C00049;C00080;C00429;C00135,33 (34),1.05e-07,1.21e-05
GABA-Transaminase Deficiency,SMPDB,9,C05665;C00386;C01152;C00025;C00222;C00049;C00080;C00429;C00135,33 (34),1.05e-07,1.21e-05
Beta-Alanine Metabolism,SMPDB,9,C05665;C00386;C01152;C00025;C00222;C00049;C00080;C00429;C00135,33 (34),1.05e-07,1.21e-05
Nicotinate and nicotinamide metabolism - Homo sapiens (human),KEGG,11,C00163;C01059;C00022;C00153;C00049;C00232;C01596;C01020;C03056;C01384;C00122,55 (55),1.23e-07,1.38e-05
Amino acid synthesis and interconversion (transamination),Reactome,10,C00077;C00064;C00148;C00033;C00022;C01005;C00740;C00025;C00049;C00080,44 (46),1.32e-07,1.44e-05
Transport of inorganic cations-anions and amino acids-oligopeptides,Wikipathways,9,C00077;C00163;C00033;C00022;C00740;C00402;C00491;C00080;C03283,34 (58),1.39e-07,1.49e-05
histidine degradation,HumanCyc,6,C00025;C03680;C00080;C00785;C00439;C00135,12 (12),2.43e-07,2.54e-05
Central carbon metabolism in cancer - Homo sapiens (human),KEGG,9,C00064;C00065;C00148;C00074;C00022;C00025;C00049;C00135;C00122,37 (37),3.09e-07,3.14e-05
Propanoate metabolism - Homo sapiens (human),KEGG,10,C00222;C00163;C00164;C17530;C00033;C00804;C00109;C05235;C00424;C06002,48 (48),3.17e-07,3.15e-05
Histidine degradation,INOH,8,C05130;C00386;C02835;C00025;C00388;C00785;C00439;C00135,28 (28),3.74e-07,3.63e-05
beta-Alanine metabolism - Homo sapiens (human),KEGG,8,C05665;C05670;C00386;C00804;C00222;C00049;C00429;C00135,32 (32),1.16e-06,0.00011
Arginine Proline metabolism,INOH,11,C02714;C00077;C00148;C02305;C00025;C04281;C00049;C05938;C00232;C00064;C00122,68 (68),1.18e-06,0.00011
Alanine Aspartate Asparagine metabolism,INOH,9,C00064;C00074;C00402;C00022;C00025;C00222;C00033;C00049;C00122,45 (45),1.84e-06,0.000167
Cysteine and methionine metabolism - Homo sapiens (human),KEGG,10,C00065;C00263;C00022;C01005;C00109;C00979;C00049;C00491;C01234;C02218,61 (61),3.28e-06,0.000291
Transport of small molecules,Reactome,18,C00077;C00064;C00163;C00148;C00388;C00178;C00033;C00022;C00740;C00025;C00402;C00164;C00049;C00491;C00080;C03283;C00475;C00135,203 (226),4.51e-06,0.000393
Alanine_ aspartate and glutamate metabolism - Homo sapiens (human),KEGG,7,C00064;C00402;C00022;C00025;C00049;C00232;C00122,28 (28),5.62e-06,0.00048
Alanine and aspartate metabolism,Wikipathways,6,C00402;C00022;C00386;C00222;C00049;C00122,19 (20),6.14e-06,0.000514
L-serine degradation,HumanCyc,4,C00065;C00022;C02218;C00080,6 (7),6.68e-06,0.000548
leukotriene biosynthesis,HumanCyc,7,C00064;C00065;C00148;C00188;C00025;C00049;C00135,29 (30),7.25e-06,0.000574
Ammonia Recycling,SMPDB,7,C00064;C00065;C00022;C00025;C00049;C00785;C00135,29 (29),7.25e-06,0.000574
D-Glutamine and D-glutamate metabolism - Homo sapiens (human),KEGG,5,C00064;C00819;C02237;C00217;C00025,12 (12),8.09e-06,0.000628
Glycine Serine metabolism,INOH,10,C00077;C00065;C02218;C00188;C00022;C01005;C00025;C00109;C05235;C01888,68 (68),9.04e-06,0.000689
Urea cycle and metabolism of amino groups,Wikipathways,7,C00077;C00148;C02565;C02305;C00025;C00049;C00122,31 (32),1.17e-05,0.000868
Histidine_ lysine_ phenylalanine_ tyrosine_ proline and tryptophan catabolism,Wikipathways,10,C00164;C00022;C00386;C03680;C02220;C00080;C00449;C00785;C00439;C00388,70 (91),1.18e-05,0.000868
Organic anion transporters,Reactome,5,C00033;C00022;C00163;C00080;C00025,14 (15),1.96e-05,0.00142
Hypoacetylaspartia,SMPDB,7,C00064;C00402;C00025;C00222;C00033;C00049;C00122,34 (34),2.24e-05,0.00154
Aspartate Metabolism,SMPDB,7,C00064;C00402;C00025;C00222;C00033;C00049;C00122,34 (34),2.24e-05,0.00154
Canavan Disease,SMPDB,7,C00064;C00402;C00025;C00222;C00033;C00049;C00122,34 (34),2.24e-05,0.00154
serine and glycine biosynthesis,HumanCyc,5,C00065;C01005;C00025;C00080;C00740,15 (15),2.88e-05,0.0019
4-hydroxyproline degradation,HumanCyc,5,C04281;C00022;C00025;C00080;C05938,15 (17),2.88e-05,0.0019
Glyoxylate and dicarboxylate metabolism - Homo sapiens (human),KEGG,9,C00064;C00065;C01732;C00033;C00022;C00258;C00025;C00266;C03618,62 (62),2.89e-05,0.0019
Metabolism of nucleotides,Reactome,13,C00064;C00349;C00178;C05512;C00022;C00025;C00222;C00087;C00049;C00080;C00429;C00475;C00122,132 (152),3.58e-05,0.00231
Methionine and cysteine metabolism,EHMN,10,C00064;C00065;C02218;C00033;C00022;C00025;C00109;C00049;C00491;C00080,80 (80),3.92e-05,0.0025
Serine biosynthesis,Reactome,5,C00022;C01005;C00025;C00080;C00740,16 (17),4.1e-05,0.00257
Pyrimidine catabolism,Reactome,7,C00222;C00178;C00022;C00349;C00080;C00429;C00475,38 (39),4.81e-05,0.00294
Pyrimidine metabolism - Homo sapiens (human),KEGG,9,C00064;C21029;C21028;C00178;C20253;C00222;C05281;C00429;C00475,66 (66),4.83e-05,0.00294
Aminoacyl-tRNA biosynthesis - Homo sapiens (human),KEGG,8,C00064;C00065;C00148;C00188;C01005;C00025;C00049;C00135,52 (52),5.33e-05,0.00312
Argininemia,SMPDB,6,C00064;C00077;C00022;C00025;C00049;C00122,27 (27),5.63e-05,0.00312
Citrullinemia Type I,SMPDB,6,C00064;C00077;C00022;C00025;C00049;C00122,27 (27),5.63e-05,0.00312
Carbamoyl Phosphate Synthetase Deficiency,SMPDB,6,C00064;C00077;C00022;C00025;C00049;C00122,27 (27),5.63e-05,0.00312
Argininosuccinic Aciduria,SMPDB,6,C00064;C00077;C00022;C00025;C00049;C00122,27 (27),5.63e-05,0.00312
Urea Cycle,SMPDB,6,C00064;C00077;C00022;C00025;C00049;C00122,27 (27),5.63e-05,0.00312
Ornithine Transcarbamylase Deficiency (OTC Deficiency),SMPDB,6,C00064;C00077;C00022;C00025;C00049;C00122,27 (27),5.63e-05,0.00312
histamine biosynthesis,HumanCyc,3,C00388;C00080;C00135,4 (4),7.06e-05,0.00382
Proton-coupled monocarboxylate transport,Reactome,3,C00022;C00164;C00080,4 (5),7.06e-05,0.00382
3-Phosphoglycerate dehydrogenase deficiency,SMPDB,8,C00065;C00022;C00258;C01005;C00025;C00109;C00740;C01888,55 (55),8.07e-05,0.00396
Non Ketotic Hyperglycinemia,SMPDB,8,C00065;C00022;C00258;C01005;C00025;C00109;C00740;C01888,55 (55),8.07e-05,0.00396
Glycine and Serine Metabolism,SMPDB,8,C00065;C00022;C00258;C01005;C00025;C00109;C00740;C01888,55 (55),8.07e-05,0.00396
Dimethylglycine Dehydrogenase Deficiency,SMPDB,8,C00065;C00022;C00258;C01005;C00025;C00109;C00740;C01888,55 (55),8.07e-05,0.00396
Hyperglycinemia_ non-ketotic,SMPDB,8,C00065;C00022;C00258;C01005;C00025;C00109;C00740;C01888,55 (55),8.07e-05,0.00396
Dimethylglycine Dehydrogenase Deficiency,SMPDB,8,C00065;C00022;C00258;C01005;C00025;C00109;C00740;C01888,55 (55),8.07e-05,0.00396
Sarcosinemia,SMPDB,8,C00065;C00022;C00258;C01005;C00025;C00109;C00740;C01888,55 (55),8.07e-05,0.00396
Dihydropyrimidine Dehydrogenase Deficiency (DHPD),SMPDB,8,C00065;C00022;C00258;C01005;C00025;C00109;C00740;C01888,55 (55),8.07e-05,0.00396
D-Arginine and D-ornithine metabolism - Homo sapiens (human),KEGG,4,C00077;C03771;C00515;C03943,10 (10),8.61e-05,0.00418
Nicotinate metabolism,Reactome,7,C00064;C00163;C00033;C00022;C00153;C00025;C00080,42 (52),9.43e-05,0.00447
Butanoate metabolism - Homo sapiens (human),KEGG,7,C00164;C00022;C00025;C06144;C00232;C01384;C00122,42 (42),9.43e-05,0.00447
Aminosugars metabolism,EHMN,7,C00064;C00074;C00033;C00022;C00740;C00025;C00080,43 (43),0.00011,0.00517
Pyruvate metabolism - Homo sapiens (human),KEGG,6,C00074;C00033;C00022;C00424;C00937;C00122,31 (31),0.000129,0.0059
Phenylalanine and tyrosine catabolism,Reactome,6,C00164;C00022;C00025;C00049;C00080;C00122,31 (31),0.000129,0.0059
asparagine biosynthesis,HumanCyc,4,C00064;C00049;C00025;C00080,11 (11),0.000133,0.00596
serine biosynthesis (phosphorylated route),HumanCyc,4,C00065;C01005;C00025;C00080,11 (11),0.000133,0.00596
Amine compound SLC transporters,Reactome,6,C00064;C00148;C00388;C00080;C03283;C00135,32 (35),0.000155,0.00689
Pyrimidine metabolism,EHMN,9,C00064;C00074;C00178;C00022;C00025;C00049;C00080;C00429;C00475,77 (77),0.000165,0.00726
Sulfur metabolism - Homo sapiens (human),KEGG,6,C00065;C00263;C04022;C00033;C00979;C00087,33 (33),0.000185,0.00807
Metabolism,Reactome,42,C00077;C00074;C00388;C02305;C00402;C05512;C00386;C00740;C02220;C00449;C01879;C00418;C05665;C00222;C00178;C00429;C00087;C14856;C00049;C00439;C00080;C00232;C00122;C00064;C00163;C00148;C00164;C00022;C00258;C03680;C00109;C00025;C00475;C05130;C00153;C01005;C00349;C04281;C00033;C03793;C00785;C00135,951 (1384),0.000205,0.00884
Glyoxylate metabolism and glycine degradation,Reactome,6,C04281;C00402;C00022;C00087;C00049;C00080,34 (43),0.00022,0.0094
Valine_ leucine and isoleucine biosynthesis - Homo sapiens (human),KEGG,5,C02226;C06007;C00022;C00109;C00188,23 (23),0.000272,0.0113
Arginine biosynthesis - Homo sapiens (human),KEGG,5,C00064;C00077;C00049;C00025;C00122,23 (23),0.000272,0.0113
histamine degradation,HumanCyc,4,C02835;C05130;C00080;C00388,13 (13),0.000276,0.0113
tyrosine degradation,HumanCyc,4,C00122;C00164;C00080;C00025,13 (13),0.000276,0.0113
Butanoate metabolism,EHMN,6,C00164;C00022;C00025;C00109;C06144;C00080,36 (36),0.000305,0.0124
Purine ribonucleoside monophosphate biosynthesis,Reactome,6,C00064;C00025;C00087;C00049;C00080;C00122,37 (37),0.000357,0.0144
Pyrimidine metabolism,Wikipathways,6,C00064;C21029;C21028;C00178;C00429;C00475,38 (40),0.000414,0.0165
Metabolism of polyamines,Reactome,7,C00077;C05665;C02305;C00025;C00049;C00080;C00122,53 (60),0.000424,0.0168
Transport of bile salts and organic acids_ metal ions and amine compounds,Reactome,8,C00064;C00148;C00388;C00022;C00080;C03283;C00135;C00164,70 (78),0.00045,0.0176
Serine biosynthesis,Wikipathways,4,C00022;C01005;C00740;C00080,15 (17),0.000505,0.0194
UTP and CTP dephosphorylation I,HumanCyc,4,C00064;C00475;C00025;C00080,15 (15),0.000505,0.0194
ABC transporters - Homo sapiens (human),KEGG,11,C00064;C00065;C00148;C00188;C00077;C00025;C01279;C00491;C00049;C03619;C00135,129 (129),0.000526,0.02
glutamine biosynthesis,HumanCyc,3,C00064;C00025;C00080,7 (7),0.000583,0.0218
carnosine biosynthesis,HumanCyc,3,C00386;C00080;C00135,7 (7),0.000583,0.0218
Pyrimidine nucleotides nucleosides metabolism,INOH,7,C00064;C00178;C00025;C00222;C00049;C00429;C00475,56 (56),0.000597,0.0222
GABA synthesis_ release_ reuptake and degradation,Reactome,4,C03283;C00025;C00080;C00232,16 (16),0.00066,0.0243
Na+/Cl- dependent neurotransmitter transporters,Reactome,5,C00064;C03283;C00148;C00388;C00135,28 (31),0.000715,0.0261
Glutaminolysis and Cancer,SMPDB,6,C00064;C00022;C00025;C00049;C00080;C00122,43 (44),0.000822,0.0297
Proximal tubule bicarbonate reclamation - Homo sapiens (human),KEGG,4,C00064;C00074;C00025;C00080,17 (17),0.000845,0.0299
urea cycle,HumanCyc,4,C00077;C00049;C00080;C00122,17 (17),0.000845,0.0299
Mineral absorption - Homo sapiens (human),KEGG,5,C00064;C00065;C00148;C00080;C00188,29 (29),0.000846,0.0299
malate-aspartate shuttle,HumanCyc,3,C00049;C00025;C00080,8 (8),0.000915,0.0315
Glutamate Neurotransmitter Release Cycle,Reactome,3,C00064;C00025;C00080,8 (8),0.000915,0.0315
L-cysteine degradation II,HumanCyc,3,C00022;C00025;C00080,8 (8),0.000915,0.0315
superpathway of purine nucleotide salvage,HumanCyc,5,C00064;C00049;C00025;C00080;C00122,30 (30),0.000994,0.0337
Tryptophan catabolism,Reactome,5,C00022;C02220;C00025;C00080;C00135,30 (34),0.000994,0.0337
Glyoxylate metabolism and glycine degradation,Wikipathways,5,C00402;C00087;C00022;C00080;C04281,31 (42),0.00116,0.0372
Pyruvate Dehydrogenase Complex Deficiency,SMPDB,6,C00074;C00033;C00022;C00424;C00937;C00080,46 (46),0.00118,0.0372
Primary hyperoxaluria II_ PH2,SMPDB,6,C00074;C00033;C00022;C00424;C00937;C00080,46 (46),0.00118,0.0372
Pyruvate kinase deficiency,SMPDB,6,C00074;C00033;C00022;C00424;C00937;C00080,46 (46),0.00118,0.0372
Leigh Syndrome,SMPDB,6,C00074;C00033;C00022;C00424;C00937;C00080,46 (46),0.00118,0.0372
Pyruvate Metabolism,SMPDB,6,C00074;C00033;C00022;C00424;C00937;C00080,46 (46),0.00118,0.0372
Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),SMPDB,6,C00074;C00033;C00022;C00424;C00937;C00080,46 (46),0.00118,0.0372
Nucleobase catabolism,Wikipathways,8,C00349;C00178;C05512;C00022;C00222;C00080;C00429;C00475,82 (100),0.0013,0.0372
UMP biosynthesis,HumanCyc,4,C00064;C00049;C00025;C00080,19 (20),0.00132,0.0372
4-aminobutyrate degradation,HumanCyc,3,C00025;C00080;C00232,9 (9),0.00135,0.0372
methylglyoxal degradation VI,HumanCyc,3,C00022;C00937;C00080,9 (9),0.00135,0.0372
proline degradation,HumanCyc,3,C00148;C00025;C00080,9 (10),0.00135,0.0372
L-glutamine tRNA biosynthesis,HumanCyc,3,C00064;C00025;C00080,9 (9),0.00135,0.0372
Miscellaneous transport and binding events,Reactome,3,C00491;C00080;C00135,9 (10),0.00135,0.0372
UDP-<i>N</i>-acetyl-D-glucosamine biosynthesis II,HumanCyc,3,C00064;C00025;C00080,9 (11),0.00135,0.0372
Histidine synthesis_ part of Histidine biosynthesis I pathway,Wikipathways,3,C00064;C00135;C01929,9 (16),0.00135,0.0372
Sialuria or French Type Sialuria,SMPDB,5,C00033;C00064;C00022;C00074;C00025,32 (32),0.00135,0.0372
Sialuria or French Type Sialuria,SMPDB,5,C00033;C00064;C00022;C00074;C00025,32 (32),0.00135,0.0372
Amino Sugar Metabolism,SMPDB,5,C00033;C00064;C00022;C00074;C00025,32 (32),0.00135,0.0372
G(M2)-Gangliosidosis: Variant B_ Tay-sachs disease,SMPDB,5,C00033;C00064;C00022;C00074;C00025,32 (32),0.00135,0.0372
Tay-Sachs Disease,SMPDB,5,C00033;C00064;C00022;C00074;C00025,32 (32),0.00135,0.0372
Salla Disease/Infantile Sialic Acid Storage Disease,SMPDB,5,C00033;C00064;C00022;C00074;C00025,32 (32),0.00135,0.0372
Nucleobase biosynthesis,Reactome,6,C00064;C00025;C00087;C00049;C00080;C00122,48 (48),0.00149,0.0372
2-Hydroxyglutric Aciduria (D And L Form),SMPDB,6,C00064;C00022;C00025;C00049;C00080;C00232,48 (49),0.00149,0.0372
Homocarnosinosis,SMPDB,6,C00064;C00022;C00025;C00049;C00080;C00232,48 (49),0.00149,0.0372
Hyperinsulinism-Hyperammonemia Syndrome,SMPDB,6,C00064;C00022;C00025;C00049;C00080;C00232,48 (49),0.00149,0.0372
Succinic semialdehyde dehydrogenase deficiency,SMPDB,6,C00064;C00022;C00025;C00049;C00080;C00232,48 (49),0.00149,0.0372
4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,SMPDB,6,C00064;C00022;C00025;C00049;C00080;C00232,48 (49),0.00149,0.0372
Glutamate Metabolism,SMPDB,6,C00064;C00022;C00025;C00049;C00080;C00232,48 (49),0.00149,0.0372
Nicotinamide salvaging,Reactome,5,C00033;C00163;C00153;C00022;C00080,33 (38),0.00155,0.0372
Propanoate metabolism,EHMN,5,C00222;C00804;C00163;C06002;C00080,33 (33),0.00155,0.0372
Troleandomycin Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Josamycin Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Methacycline Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Streptomycin Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Spectinomycin Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Kanamycin Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Gentamicin Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Netilmicin Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Neomycin Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Roxithromycin Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Erythromycin Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Amikacin Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Telithromycin Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Tobramycin Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Tigecycline Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Arbekacin Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Paromomycin Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Doxycycline Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Oxytetracycline Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Minocycline Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Lymecycline Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Tetracycline Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Clomocycline Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Lincomycin Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Rolitetracycline Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Chloramphenicol Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Clarithromycin Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Clindamycin Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Azithromycin Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,20 (20),0.00162,0.0372
Nucleobase catabolism,Reactome,8,C00349;C00178;C05512;C00022;C00222;C00080;C00429;C00475,86 (100),0.00178,0.0403
Glutamate Glutamine metabolism,INOH,5,C00064;C00022;C00049;C00025;C00232,34 (34),0.00178,0.0403
Gluconeogenesis,Reactome,5,C00049;C00022;C00074;C00025;C00080,34 (34),0.00178,0.0403
asparagine degradation,HumanCyc,3,C00049;C00025;C00080,10 (10),0.00189,0.0419
L-cysteine degradation I,HumanCyc,3,C00022;C00025;C00080,10 (10),0.00189,0.0419
Malate-Aspartate Shuttle,SMPDB,3,C00049;C00025;C00080,10 (10),0.00189,0.0419
Demeclocycline Action Pathway,SMPDB,4,C00148;C00135;C00740;C00188,21 (21),0.00196,0.0433
Proton/oligopeptide cotransporters,Reactome,2,C00080;C00135,3 (5),0.00204,0.0447
Uptake and function of diphtheria toxin,Wikipathways,2,C00153;C00080,3 (3),0.00204,0.0447
superpathway of methionine degradation,HumanCyc,5,C00065;C00022;C00080;C00025;C00109,36 (36),0.00232,0.0503
Pyrimidine biosynthesis,Reactome,4,C00064;C00049;C00025;C00080,22 (22),0.00235,0.0503
Taurine and hypotaurine metabolism - Homo sapiens (human),KEGG,4,C00033;C00022;C06735;C00025,22 (22),0.00235,0.0503
superpathway of pyrimidine ribonucleotides <i>de novo</i> biosynthesis,HumanCyc,4,C00064;C00049;C00025;C00080,22 (23),0.00235,0.0503
UTP and CTP dephosphorylation II,HumanCyc,3,C00064;C00025;C00080,11 (11),0.00254,0.0532
acetone degradation I (to methylglyoxal),HumanCyc,3,C00164;C00080;C05235,11 (11),0.00254,0.0532
Proline catabolism,Reactome,3,C00148;C00025;C00080,11 (11),0.00254,0.0532
Glucose-Alanine Cycle,SMPDB,3,C00022;C00025;C00080,11 (11),0.00254,0.0532
UTP and CTP <i>de novo</i> biosynthesis,HumanCyc,3,C00064;C00025;C00080,11 (11),0.00254,0.0532
purine nucleotides <i>de novo</i> biosynthesis,HumanCyc,5,C00064;C00049;C00025;C00080;C00122,37 (37),0.00262,0.0546
Urea cycle,Reactome,4,C00077;C00049;C00025;C00122,23 (23),0.00278,0.0577
Nicotinate metabolism,Wikipathways,5,C00033;C00022;C00153;C00163;C00080,38 (55),0.00296,0.061
Purine metabolism,EHMN,8,C00064;C00074;C05512;C00022;C00025;C00049;C00080;C00122,94 (94),0.00313,0.0643
Pyrimidine metabolism and related diseases,Wikipathways,4,C00475;C00429;C00178;C00515,24 (31),0.00327,0.0668
The oncogenic action of 2-hydroxyglutarate,SMPDB,5,C00064;C00022;C00025;C00080;C00122,39 (40),0.00332,0.067
adenosine ribonucleotides <i>de novo</i> biosynthesis,HumanCyc,3,C00049;C00080;C00122,12 (12),0.00333,0.067
Synaptic vesicle cycle - Homo sapiens (human),KEGG,3,C00388;C00080;C00025,12 (12),0.00333,0.067
Glycerophospholipid metabolism,EHMN,8,C00064;C00065;C00188;C00033;C00258;C00222;C00491;C00080,96 (96),0.00357,0.0716
Warburg Effect,SMPDB,6,C00064;C00074;C00022;C00025;C00080;C00122,57 (58),0.00362,0.0723
The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria,SMPDB,5,C00064;C00022;C00025;C00080;C00122,40 (41),0.00372,0.0735
The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria ,SMPDB,5,C00064;C00022;C00025;C00080;C00122,40 (41),0.00372,0.0735
G alpha (q) signalling events,Reactome,6,C00077;C00163;C00388;C00033;C00025;C00080,58 (63),0.00395,0.0752
glutamate dependent acid resistance,HumanCyc,2,C00025;C00080,4 (4),0.00401,0.0752
aspartate biosynthesis,HumanCyc,2,C00049;C00025,4 (4),0.00401,0.0752
Cleavage of the damaged pyrimidine ,Reactome,2,C00429;C00178,4 (9),0.00401,0.0752
Depyrimidination,Reactome,2,C00429;C00178,4 (9),0.00401,0.0752
Proton-coupled neutral amino acid transporters,Reactome,2,C00148;C00080,4 (4),0.00401,0.0752
alanine biosynthesis/degradation,HumanCyc,2,C00022;C00025,4 (4),0.00401,0.0752
putrescine biosynthesis I,HumanCyc,2,C00077;C00080,4 (4),0.00401,0.0752
glutamine degradation/glutamate biosynthesis,HumanCyc,2,C00064;C00025,4 (4),0.00401,0.0752
Methylhistidine Metabolism,SMPDB,2,C01152;C00135,4 (4),0.00401,0.0752
TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer,Wikipathways,2,C00819;C00022,4 (4),0.00401,0.0752
SCFA and skeletal muscle substrate metabolism,Wikipathways,2,C00033;C00163,4 (4),0.00401,0.0752
Neurotransmitter release cycle,Reactome,5,C00064;C03283;C00025;C00080;C00232,41 (45),0.00415,0.0773
Tyrosine metabolism - Homo sapiens (human),KEGG,7,C00164;C00022;C05600;C03063;C00232;C01384;C00122,78 (78),0.00422,0.0777
Glycolysis and Gluconeogenesis,Wikipathways,3,C00049;C00022;C00074,13 (18),0.00424,0.0777
GABA shunt,HumanCyc,3,C00025;C00080;C00232,13 (13),0.00424,0.0777
Famotidine Action Pathway,SMPDB,3,C00025;C00080;C00388,13 (13),0.00424,0.0777
Propanoate metabolism,INOH,4,C00804;C00163;C06002;C00109,26 (26),0.00442,0.0806
Purine nucleotides nucleosides metabolism,INOH,7,C00064;C00074;C05512;C00022;C00025;C00049;C00122,80 (80),0.00485,0.0882
Trans-sulfuration pathway,Wikipathways,4,C00022;C00109;C00025;C02305,27 (28),0.00508,0.0912
Transmission across Chemical Synapses,Reactome,6,C00064;C00033;C00025;C00080;C00232;C03283,61 (65),0.00509,0.0912
Neuronal System,Reactome,6,C00064;C00033;C00025;C00080;C00232;C03283,61 (65),0.00509,0.0912
Glucose metabolism,Reactome,5,C00049;C00022;C00074;C00025;C00080,43 (44),0.00511,0.0912
glutathione-mediated detoxification,HumanCyc,3,C00022;C00025;C00080,14 (14),0.00529,0.0912
NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde,HumanCyc,3,C00064;C00025;C00080,14 (14),0.00529,0.0912
Synthesis of Ketone Bodies,Reactome,3,C00033;C00164;C00080,14 (14),0.00529,0.0912
citrulline-nitric oxide cycle,HumanCyc,3,C00049;C00080;C00122,14 (14),0.00529,0.0912
Aflatoxin activation and detoxification,Reactome,3,C00033;C00025;C00080,14 (25),0.00529,0.0912
pyrimidine ribonucleosides degradation,HumanCyc,3,C00475;C00429;C00080,14 (14),0.00529,0.0912
GABA synthesis_ release_ reuptake and degradation,Wikipathways,3,C03283;C00080;C00232,14 (16),0.00529,0.0912
proline biosynthesis,HumanCyc,3,C00148;C00025;C00080,14 (14),0.00529,0.0912
Vitamin B6-dependent and responsive disorders,Wikipathways,3,C00148;C00025;C00449,14 (18),0.00529,0.0912
Pantothenate and CoA biosynthesis - Homo sapiens (human),KEGG,4,C00022;C00049;C00522;C00429,28 (28),0.00581,0.0997
Generic Transcription Pathway,Reactome,5,C00033;C00064;C00153;C00025;C00080,45 (49),0.00622,0.106
Methionine Cysteine metabolism,INOH,5,C00065;C00022;C00491;C00025;C00109,45 (45),0.00622,0.106
ornithine <i>de novo </i> biosynthesis,HumanCyc,3,C00077;C00025;C00080,15 (15),0.00649,0.108
guanosine ribonucleotides <i>de novo</i> biosynthesis,HumanCyc,3,C00064;C00025;C00080,15 (15),0.00649,0.108
Bile salt and organic anion SLC transporters,Reactome,3,C00022;C00164;C00080,15 (17),0.00649,0.108
putrescine degradation III,HumanCyc,3,C02714;C00033;C00080,15 (15),0.00649,0.108
Creatine metabolism,Reactome,3,C00077;C02305;C00080,15 (15),0.00649,0.108
lactate fermentation (reoxidation of cytosolic NADH),HumanCyc,2,C00022;C00080,5 (5),0.00657,0.108
creatine-phosphate biosynthesis,HumanCyc,2,C02305;C00080,5 (5),0.00657,0.108
GABA synthesis,Reactome,2,C00025;C00080,5 (5),0.00657,0.108
Folate metabolism,INOH,5,C00065;C00022;C00074;C00025;C00439,46 (46),0.00683,0.112
inosine-5_-phosphate biosynthesis,HumanCyc,3,C00049;C00080;C00122,16 (16),0.00784,0.126
Ketone body metabolism,Reactome,3,C00033;C00164;C00080,16 (16),0.00784,0.126
Base Excision Repair,Reactome,3,C00153;C00429;C00178,16 (22),0.00784,0.126
lysine degradation I (saccharopine pathway),HumanCyc,3,C00025;C00080;C00449,16 (16),0.00784,0.126
Ketone body metabolism,Wikipathways,3,C00033;C00164;C00080,16 (16),0.00784,0.126
RNA Polymerase II Transcription,Reactome,5,C00033;C00064;C00153;C00025;C00080,48 (52),0.00818,0.131
Pyruvate metabolism,INOH,4,C00033;C00022;C00074;C00164,31 (31),0.0084,0.134
Metabolism of ingested SeMet_ Sec_ MeSec into H2Se,Reactome,4,C00022;C00153;C00388;C00109,31 (32),0.0084,0.134
Biogenic Amine Synthesis,Wikipathways,3,C00135;C00025;C00388,17 (17),0.00933,0.147
guanosine nucleotides <i>de novo</i> biosynthesis,HumanCyc,3,C00064;C00025;C00080,17 (17),0.00933,0.147
5-aminoimidazole ribonucleotide biosynthesis,HumanCyc,3,C00064;C00025;C00080,17 (17),0.00933,0.147
Human metabolism overview,Wikipathways,8,C00064;C00077;C00074;C00164;C00022;C00025;C00049;C00122,113 (113),0.0095,0.149
Neurotransmitter uptake and metabolism In glial cells,Reactome,2,C00064;C00025,6 (6),0.00969,0.15
homocarnosine biosynthesis,HumanCyc,2,C00080;C00135,6 (7),0.00969,0.15
Astrocytic Glutamate-Glutamine Uptake And Metabolism,Reactome,2,C00064;C00025,6 (6),0.00969,0.15
Miscellaneous transport and binding events,Wikipathways,2,C00491;C00080,6 (10),0.00969,0.15
superpathway of pyrimidine deoxyribonucleotides <i>de novo</i> biosynthesis,HumanCyc,4,C00064;C00049;C00025;C00080,33 (34),0.0105,0.161
Amino acid synthesis and interconversion (transamination),Wikipathways,4,C00077;C00033;C00022;C00080,33 (40),0.0105,0.161
superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle,HumanCyc,4,C00022;C00074;C00080;C00122,34 (36),0.0117,0.178
Degradation of cysteine and homocysteine,Reactome,4,C00022;C00080;C00025;C00109,34 (39),0.0117,0.178
Transport of bile salts and organic acids_ metal ions and amine compounds,Wikipathways,5,C03283;C00022;C00388;C00080;C00164,53 (77),0.0124,0.187
Selenoamino acid metabolism,Wikipathways,5,C00022;C00153;C00109;C00388;C00080,53 (59),0.0124,0.187
glycolysis,HumanCyc,3,C00022;C00074;C00080,19 (20),0.0128,0.192
TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc),Wikipathways,3,C00022;C00074;C00122,19 (19),0.0128,0.192
Citrate cycle,INOH,4,C00022;C00074;C00164;C00122,35 (35),0.0129,0.192
Transcriptional Regulation by TP53,Reactome,4,C00033;C00064;C00025;C00080,35 (37),0.0129,0.192
Nicotinate and Nicotinamide Metabolism,SMPDB,4,C00064;C00153;C00025;C00080,35 (35),0.0129,0.192
NAD salvage,HumanCyc,2,C00153;C00080,7 (7),0.0133,0.195
<i>N</i>-acetylglucosamine degradation II,HumanCyc,2,C00033;C00080,7 (9),0.0133,0.195
cysteine biosynthesis/homocysteine degradation (trans-sulfuration),HumanCyc,2,C00065;C00109,7 (7),0.0133,0.195
pyruvate decarboxylation to acetyl CoA,HumanCyc,2,C00022;C00080,7 (7),0.0133,0.195
Cytosolic iron-sulfur cluster assembly,Wikipathways,2,C00087;C00080,7 (10),0.0133,0.195
Disulfiram Action Pathway,SMPDB,6,C00164;C00033;C00025;C00049;C00080;C00122,75 (77),0.0137,0.2
TCA cycle,EHMN,4,C00033;C00074;C00080;C00122,36 (36),0.0142,0.206
Vitamin B3 (nicotinate and nicotinamide) metabolism,EHMN,4,C00064;C00153;C00025;C00080,36 (36),0.0142,0.206
Metabolism of water-soluble vitamins and cofactors,Reactome,7,C00064;C00163;C00033;C00022;C00153;C00025;C00080,98 (122),0.0143,0.207
Citrate cycle (TCA cycle) - Homo sapiens (human),KEGG,3,C00022;C00074;C00122,20 (20),0.0148,0.209
Synthesis of UDP-N-acetyl-glucosamine,Reactome,3,C00064;C00025;C00080,20 (21),0.0148,0.209
Sialic acid metabolism,Reactome,3,C00022;C00074;C00080,20 (27),0.0148,0.209
leucine degradation,HumanCyc,3,C00164;C00080;C00025,20 (20),0.0148,0.209
valine degradation,HumanCyc,3,C06002;C00025;C00080,20 (20),0.0148,0.209
Sialic acid metabolism,Wikipathways,3,C00022;C00074;C00080,20 (27),0.0148,0.209
Selenoamino acid metabolism,Reactome,5,C00022;C00153;C00080;C00109;C00388,56 (61),0.0155,0.218
Gene expression (Transcription),Reactome,5,C00033;C00064;C00153;C00025;C00080,57 (66),0.0166,0.232
Synthesis of substrates in N-glycan biosythesis,Reactome,5,C00064;C00022;C00074;C00025;C00080,57 (68),0.0166,0.232
Glucose Homeostasis,Wikipathways,3,C00077;C00022;C00135,21 (21),0.0169,0.232
Malonyl-coa decarboxylase deficiency,SMPDB,4,C00222;C00163;C00025;C06002,38 (38),0.0171,0.232
Malonic Aciduria,SMPDB,4,C00222;C00163;C00025;C06002,38 (38),0.0171,0.232
Propanoate Metabolism,SMPDB,4,C00222;C00163;C00025;C06002,38 (38),0.0171,0.232
Methylmalonic Aciduria Due to Cobalamin-Related Disorders,SMPDB,4,C00222;C00163;C00025;C06002,38 (38),0.0171,0.232
creatine biosynthesis,HumanCyc,2,C00077;C00080,8 (8),0.0175,0.232
4-hydroxy-2-nonenal detoxification,HumanCyc,2,C00025;C00080,8 (8),0.0175,0.232
methylglyoxal degradation III,HumanCyc,2,C00080;C05235,8 (8),0.0175,0.232
Base-Excision Repair_ AP Site Formation,Reactome,2,C00429;C00178,8 (14),0.0175,0.232
pyrimidine ribonucleosides degradation,HumanCyc,2,C00475;C00080,8 (8),0.0175,0.232
heparan sulfate biosynthesis (late stages),HumanCyc,2,C00033;C00080,8 (8),0.0175,0.232
Glutamatergic synapse - Homo sapiens (human),KEGG,2,C00064;C00025,8 (8),0.0175,0.232
Homocysteine Degradation,SMPDB,2,C00065;C00109,8 (8),0.0175,0.232
Gamma-cystathionase deficiency (CTH),SMPDB,2,C00065;C00109,8 (8),0.0175,0.232
Homocystinuria_ cystathionine beta-synthase deficiency,SMPDB,2,C00065;C00109,8 (8),0.0175,0.232
threonine degradation,HumanCyc,2,C00109;C00188,8 (8),0.0175,0.232
Base-Excision Repair_ AP Site Formation,Wikipathways,2,C00429;C00178,8 (14),0.0175,0.232
superpathway of tryptophan utilization,HumanCyc,5,C00033;C00064;C02220;C00025;C00080,59 (70),0.019,0.252
Tyrosine metabolism,EHMN,7,C00065;C00164;C00022;C00025;C00080;C00122;C02218,105 (105),0.0203,0.267
The oncogenic action of Succinate,SMPDB,4,C00022;C00148;C00080;C00122,40 (41),0.0204,0.267
TP53 Regulates Metabolic Genes,Reactome,3,C00064;C00025;C00080,23 (25),0.0217,0.274
Glycolysis Pathway D (2),Wikipathways,2,C00022;C00074,9 (14),0.0221,0.274
Acetylcholine Synthesis,Wikipathways,2,C00033;C00022,9 (9),0.0221,0.274
glutamate biosynthesis/degradation,HumanCyc,2,C00025;C00080,9 (9),0.0221,0.274
pyrimidine ribonucleosides salvage I,HumanCyc,2,C00475;C00080,9 (9),0.0221,0.274
selenocysteine biosynthesis,HumanCyc,2,C00065;C00080,9 (10),0.0221,0.274
GABAergic synapse - Homo sapiens (human),KEGG,2,C00064;C00025,9 (9),0.0221,0.274
pyrimidine deoxyribonucleosides degradation,HumanCyc,2,C00178;C00080,9 (10),0.0221,0.274
methylglyoxal degradation I,HumanCyc,2,C00022;C00080,9 (11),0.0221,0.274
purine deoxyribonucleosides degradation,HumanCyc,2,C05512;C00080,9 (10),0.0221,0.274
Multifunctional anion exchangers,Reactome,2,C00022;C00080,9 (10),0.0221,0.274
Degradation of GABA,Reactome,2,C00025;C00232,9 (9),0.0221,0.274
melatonin degradation II,HumanCyc,2,C00033;C00080,9 (11),0.0221,0.274
7-(3-amino-3-carboxypropyl)-wyosine biosynthesis,HumanCyc,2,C00022;C00080,9 (9),0.0221,0.274
wybutosine biosynthesis,HumanCyc,2,C00022;C00080,9 (9),0.0221,0.274
Pyruvaldehyde Degradation,SMPDB,2,C00022;C00080,9 (9),0.0221,0.274
glutathione biosynthesis,HumanCyc,2,C00025;C00080,9 (9),0.0221,0.274
L-dopa degradation,HumanCyc,2,C00025;C00080,9 (12),0.0221,0.274
tRNA splicing,HumanCyc,2,C00153;C00080,9 (11),0.0221,0.274
The oncogenic action of Fumarate,SMPDB,4,C00022;C00148;C00080;C00122,41 (42),0.0221,0.274
Valine_ leucine and isoleucine degradation,EHMN,5,C00349;C06002;C00164;C00080;C00025,62 (62),0.0231,0.285
One carbon metabolism and related pathways,Wikipathways,4,C00217;C00065;C01879;C00109,42 (42),0.0239,0.295
NAD <i>de novo</i> biosynthesis,HumanCyc,3,C00064;C00025;C00080,24 (24),0.0243,0.298
Cytosolic tRNA aminoacylation,Reactome,5,C00064;C00049;C00148;C00025;C00135,63 (66),0.0246,0.299
Mitochondrial tRNA aminoacylation,Reactome,5,C00064;C00049;C00148;C00025;C00135,63 (66),0.0246,0.299
tRNA Aminoacylation,Reactome,5,C00064;C00049;C00148;C00025;C00135,63 (66),0.0246,0.299
The citric acid (TCA) cycle and respiratory electron transport,Wikipathways,4,C00022;C00122;C00080;C00232,43 (44),0.0259,0.313
Nucleotide salvage,Wikipathways,4,C00475;C05512;C00080;C00178,43 (45),0.0259,0.313
Uncoating of the Influenza Virion,Reactome,1,C00080,1 (1),0.0264,0.316
Fusion and Uncoating of the Influenza Virion,Reactome,1,C00080,1 (1),0.0264,0.316
Histamine receptors,Reactome,1,C00388,1 (1),0.0264,0.316
ERK Pathway in Huntington_s Disease,Wikipathways,1,C00025,1 (1),0.0264,0.316
Metabolism of carbohydrates,Reactome,7,C00074;C00033;C00022;C00258;C00025;C00049;C00080,111 (137),0.0266,0.317
gluconeogenesis,HumanCyc,3,C00022;C00074;C00080,25 (26),0.0271,0.317
thymine degradation,HumanCyc,2,C00178;C00080,10 (10),0.0271,0.317
ketolysis,HumanCyc,2,C00164;C00080,10 (10),0.0271,0.317
Utilization of Ketone Bodies,Reactome,2,C00164;C00080,10 (10),0.0271,0.317
heparan sulfate biosynthesis,HumanCyc,2,C00033;C00080,10 (10),0.0271,0.317
uracil degradation,HumanCyc,2,C00429;C00080,10 (10),0.0271,0.317
Putative anti-Inflammatory metabolites formation from EPA,EHMN,2,C00025;C00080,10 (10),0.0271,0.317
Tyrosinemia_ transient_ of the newborn,SMPDB,5,C00122;C00049;C00025;C00080;C00164,65 (67),0.0277,0.318
Dopamine beta-hydroxylase deficiency,SMPDB,5,C00122;C00049;C00025;C00080;C00164,65 (67),0.0277,0.318
Tyrosine Metabolism,SMPDB,5,C00122;C00049;C00025;C00080;C00164,65 (67),0.0277,0.318
Alkaptonuria,SMPDB,5,C00122;C00049;C00025;C00080;C00164,65 (67),0.0277,0.318
Monoamine oxidase-a deficiency (MAO-A),SMPDB,5,C00122;C00049;C00025;C00080;C00164,65 (67),0.0277,0.318
Hawkinsinuria,SMPDB,5,C00122;C00049;C00025;C00080;C00164,65 (67),0.0277,0.318
Tyrosinemia Type I,SMPDB,5,C00122;C00049;C00025;C00080;C00164,65 (67),0.0277,0.318
Pyruvate metabolism and Citric Acid (TCA) cycle,Reactome,4,C00022;C00122;C00080;C00232,44 (44),0.0279,0.319
Nucleotide salvage,Reactome,4,C00475;C05512;C00080;C00178,44 (45),0.0279,0.319
Glucagon signaling pathway - Homo sapiens (human),KEGG,3,C00022;C00074;C00122,26 (26),0.0301,0.341
Nicotinate Nicotinamide metabolism,INOH,3,C00064;C00153;C00025,26 (26),0.0301,0.341
&beta;-alanine degradation,HumanCyc,2,C00222;C00025,11 (11),0.0326,0.366
D-Arginine and D-Ornithine Metabolism,SMPDB,2,C03771;C00515,11 (11),0.0326,0.366
dTMP <i>de novo</i> biosynthesis (mitochondrial),HumanCyc,2,C00065;C00080,11 (11),0.0326,0.366
Disorders of the Krebs cycle,Wikipathways,2,C00022;C00122,11 (14),0.0326,0.366
G alpha (q) signalling events,Wikipathways,4,C00033;C00163;C00388;C00080,47 (52),0.0345,0.385
Branched-chain amino acid catabolism,Reactome,4,C00349;C03793;C00025;C00080,47 (47),0.0345,0.385
Metabolism of polyamines,Wikipathways,4,C00077;C05665;C00080;C02305,47 (59),0.0345,0.385
Glutathione conjugation,Reactome,3,C14856;C00025;C01879,28 (31),0.0365,0.401
Phenylalanine and Tyrosine Metabolism,SMPDB,3,C00122;C00025;C00164,28 (28),0.0365,0.401
Phenylketonuria,SMPDB,3,C00122;C00025;C00164,28 (28),0.0365,0.401
Tyrosinemia Type 3 (TYRO3),SMPDB,3,C00122;C00025;C00164,28 (28),0.0365,0.401
Tyrosinemia Type 2 (or Richner-Hanhart syndrome),SMPDB,3,C00122;C00025;C00164,28 (28),0.0365,0.401
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide_ LLO) and transfer to a nascent protein,Reactome,5,C00064;C00022;C00074;C00025;C00080,70 (81),0.0367,0.402
ketogenesis,HumanCyc,2,C00164;C00080,12 (12),0.0384,0.413
ethanol degradation II,HumanCyc,2,C00033;C00080,12 (12),0.0384,0.413
2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA,HumanCyc,2,C02220;C00080,12 (12),0.0384,0.413
Gastric Acid Production,SMPDB,2,C00388;C00080,12 (12),0.0384,0.413
Betazole Action Pathway,SMPDB,2,C00388;C00080,12 (13),0.0384,0.413
Roxatidine acetate Action Pathway,SMPDB,2,C00388;C00080,12 (12),0.0384,0.413
Threonine catabolism,Wikipathways,2,C00080;C00109,12 (15),0.0384,0.413
fig-met-1-last-solution,Wikipathways,2,C00022;C00122,12 (14),0.0384,0.413
Lipid Metabolism Pathway,Wikipathways,2,C00033;C00022,12 (14),0.0384,0.413
Metabolic reprogramming in colon cancer,Wikipathways,3,C00022;C00074;C00122,29 (35),0.0399,0.419
Translation,Reactome,5,C00064;C00049;C00148;C00025;C00135,72 (78),0.0407,0.419
Purine Nucleoside Phosphorylase Deficiency,SMPDB,5,C00064;C05512;C00049;C00025;C00122,72 (73),0.0407,0.419
Xanthine Dehydrogenase Deficiency (Xanthinuria),SMPDB,5,C00064;C05512;C00049;C00025;C00122,72 (73),0.0407,0.419
Adenylosuccinate Lyase Deficiency,SMPDB,5,C00064;C05512;C00049;C00025;C00122,72 (73),0.0407,0.419
AICA-Ribosiduria,SMPDB,5,C00064;C05512;C00049;C00025;C00122,72 (73),0.0407,0.419
Adenine phosphoribosyltransferase deficiency (APRT),SMPDB,5,C00064;C05512;C00049;C00025;C00122,72 (73),0.0407,0.419
Mitochondrial DNA depletion syndrome,SMPDB,5,C00064;C05512;C00049;C00025;C00122,72 (73),0.0407,0.419
Myoadenylate deaminase deficiency,SMPDB,5,C00064;C05512;C00049;C00025;C00122,72 (73),0.0407,0.419
Purine Metabolism,SMPDB,5,C00064;C05512;C00049;C00025;C00122,72 (73),0.0407,0.419
Molybdenum Cofactor Deficiency,SMPDB,5,C00064;C05512;C00049;C00025;C00122,72 (73),0.0407,0.419
Adenosine Deaminase Deficiency,SMPDB,5,C00064;C05512;C00049;C00025;C00122,72 (73),0.0407,0.419
Gout or Kelley-Seegmiller Syndrome,SMPDB,5,C00064;C05512;C00049;C00025;C00122,72 (73),0.0407,0.419
Lesch-Nyhan Syndrome (LNS),SMPDB,5,C00064;C05512;C00049;C00025;C00122,72 (73),0.0407,0.419
Xanthinuria type I,SMPDB,5,C00064;C05512;C00049;C00025;C00122,72 (73),0.0407,0.419
Xanthinuria type II,SMPDB,5,C00064;C05512;C00049;C00025;C00122,72 (73),0.0407,0.419
Lysine catabolism,Reactome,3,C00025;C00080;C00449,30 (32),0.0435,0.445
Citric acid cycle (TCA cycle),Reactome,3,C00022;C00080;C00122,30 (30),0.0435,0.445
L-kynurenine degradation,HumanCyc,3,C02220;C00025;C00080,30 (30),0.0435,0.445
CMP-<i>N</i>-acetylneuraminate biosynthesis I (eukaryotes),HumanCyc,2,C00074;C00080,13 (15),0.0447,0.445
folate polyglutamylation,HumanCyc,2,C00065;C00025,13 (13),0.0447,0.445
ethanol degradation IV,HumanCyc,2,C00033;C00080,13 (13),0.0447,0.445
Esomeprazole Action Pathway,SMPDB,2,C00388;C00080,13 (13),0.0447,0.445
Lansoprazole Action Pathway,SMPDB,2,C00388;C00080,13 (13),0.0447,0.445
Nizatidine Action Pathway,SMPDB,2,C00388;C00080,13 (13),0.0447,0.445
Cimetidine Action Pathway,SMPDB,2,C00388;C00080,13 (13),0.0447,0.445
Ranitidine Action Pathway,SMPDB,2,C00388;C00080,13 (13),0.0447,0.445
Metiamide Action Pathway,SMPDB,2,C00388;C00080,13 (13),0.0447,0.445
Pirenzepine Action Pathway,SMPDB,2,C00388;C00080,13 (13),0.0447,0.445
Threonine catabolism,Reactome,2,C00109;C00080,13 (15),0.0447,0.445
mRNA_ protein_ and metabolite inducation pathway by cyclosporin A,Wikipathways,2,C00064;C00188,13 (13),0.0447,0.445
Thiamine metabolism - Homo sapiens (human),KEGG,3,C00022;C01279;C04294,31 (31),0.0473,0.465
Ferroptosis - Homo sapiens (human),KEGG,3,C00491;C00418;C00025,31 (31),0.0473,0.465
Glycolysis,Reactome,3,C00022;C00074;C00080,31 (32),0.0473,0.465
Glycolysis / Gluconeogenesis - Homo sapiens (human),KEGG,3,C00033;C00022;C00074,31 (31),0.0473,0.465
Trans-sulfuration and one carbon metabolism,Wikipathways,3,C00077;C00065;C01005,31 (33),0.0473,0.465
Glycolysis and Gluconeogenesis,EHMN,4,C00033;C00022;C00074;C00080,52 (52),0.0474,0.466
Lysine metabolism,EHMN,4,C03793;C00025;C00080;C00449,53 (53),0.0503,0.475
Aminosugars metabolism,INOH,3,C00064;C00074;C00025,32 (32),0.0512,0.475
Pyruvate dehydrogenase deficiency (E3),SMPDB,3,C00022;C00080;C00122,32 (33),0.0512,0.475
Pyruvate dehydrogenase deficiency (E2),SMPDB,3,C00022;C00080;C00122,32 (33),0.0512,0.475
2-ketoglutarate dehydrogenase complex deficiency,SMPDB,3,C00022;C00080;C00122,32 (33),0.0512,0.475
Mitochondrial complex II deficiency,SMPDB,3,C00022;C00080;C00122,32 (33),0.0512,0.475
Fumarase deficiency,SMPDB,3,C00022;C00080;C00122,32 (33),0.0512,0.475
Congenital lactic acidosis,SMPDB,3,C00022;C00080;C00122,32 (33),0.0512,0.475
Citric Acid Cycle,SMPDB,3,C00022;C00080;C00122,32 (33),0.0512,0.475
L-carnitine biosynthesis,HumanCyc,2,C03793;C00080,14 (14),0.0512,0.475
Glutathione synthesis and recycling,Reactome,2,C00025;C01879,14 (14),0.0512,0.475
Gastric acid secretion - Homo sapiens (human),KEGG,2,C00388;C00080,14 (14),0.0512,0.475
2-oxobutanoate degradation,HumanCyc,2,C00109;C00080,14 (14),0.0512,0.475
Pantoprazole Action Pathway,SMPDB,2,C00388;C00080,14 (14),0.0512,0.475
Rabeprazole Action Pathway,SMPDB,2,C00388;C00080,14 (14),0.0512,0.475
Omeprazole Action Pathway,SMPDB,2,C00388;C00080,14 (14),0.0512,0.475
Trans-sulfuration pathway,Wikipathways,2,C00022;C00025,14 (14),0.0512,0.475
NAD+ metabolism,Wikipathways,2,C00022;C00153,14 (14),0.0512,0.475
phosphatidylserine biosynthesis II,HumanCyc,1,C00065,2 (4),0.0522,0.475
DNA Damage Recognition in GG-NER,Reactome,1,C00153,2 (2),0.0522,0.475
Insulin receptor recycling,Reactome,1,C00080,2 (2),0.0522,0.475
HDACs deacetylate histones,Reactome,1,C00033,2 (3),0.0522,0.475
Sodium/Proton exchangers,Reactome,1,C00080,2 (2),0.0522,0.475
Uptake and function of diphtheria toxin,Reactome,1,C00153,2 (2),0.0522,0.475
Presynaptic function of Kainate receptors,Reactome,1,C00025,2 (2),0.0522,0.475
Rhesus glycoproteins mediate ammonium transport.,Reactome,1,C00080,2 (2),0.0522,0.475
phosphatidylserine biosynthesis I,HumanCyc,1,C00065,2 (4),0.0522,0.475
Synaptic adhesion-like molecules,Reactome,1,C00025,2 (2),0.0522,0.475
thyronamine and iodothyronamine metabolism,HumanCyc,1,C00080,2 (11),0.0522,0.475
Protein-protein interactions at synapses,Reactome,1,C00025,2 (2),0.0522,0.475
Esomeprazole Metabolism Pathway,SMPDB,1,C00080,2 (2),0.0522,0.475
Lansoprazole Metabolism Pathway,SMPDB,1,C00080,2 (2),0.0522,0.475
Degradation of AXIN,Reactome,1,C00153,2 (2),0.0522,0.475
SALM protein interactions at the synapse,Wikipathways,1,C00025,2 (2),0.0522,0.475
The citric acid (TCA) cycle and respiratory electron transport,Reactome,4,C00022;C00122;C00080;C00232,54 (56),0.0533,0.483
Sulfur amino acid metabolism,Reactome,4,C00022;C00109;C00025;C00080,54 (66),0.0533,0.483
Taste transduction - Homo sapiens (human),KEGG,3,C00740;C00080;C00025,33 (33),0.0553,0.5
Lysine degradation - Homo sapiens (human),KEGG,4,C03087;C03793;C00164;C00449,55 (55),0.0563,0.509
ceramide <i>de novo</i> biosynthesis,HumanCyc,2,C00065;C00080,15 (20),0.0581,0.519
Ethanol oxidation,Reactome,2,C00033;C00080,15 (15),0.0581,0.519
Carnitine synthesis,Reactome,2,C03793;C00080,15 (15),0.0581,0.519
oxidative ethanol degradation III,HumanCyc,2,C00033;C00080,15 (15),0.0581,0.519
Hereditary leiomyomatosis and renal cell carcinoma pathway,Wikipathways,2,C00022;C00122,15 (21),0.0581,0.519
Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1),SMPDB,3,C00022;C00074;C00080,34 (34),0.0595,0.522
Glycolysis Gluconeogenesis,INOH,3,C00022;C00074;C00025,34 (34),0.0595,0.522
Gluconeogenesis,SMPDB,3,C00022;C00074;C00080,34 (34),0.0595,0.522
Glycogenosis_ Type IA. Von gierke disease,SMPDB,3,C00022;C00074;C00080,34 (34),0.0595,0.522
Glycogenosis_ Type IC,SMPDB,3,C00022;C00074;C00080,34 (34),0.0595,0.522
Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease,SMPDB,3,C00022;C00074;C00080,34 (34),0.0595,0.522
Triosephosphate isomerase,SMPDB,3,C00022;C00074;C00080,34 (34),0.0595,0.522
Fructose-1_6-diphosphatase deficiency,SMPDB,3,C00022;C00074;C00080,34 (34),0.0595,0.522
Glycogenosis_ Type IB,SMPDB,3,C00022;C00074;C00080,34 (34),0.0595,0.522
Phosphonate and phosphinate metabolism - Homo sapiens (human),KEGG,4,C00033;C00022;C00074;C02798,57 (57),0.0627,0.542
Pyrimidine Metabolism,SMPDB,4,C00064;C00178;C00429;C00475,57 (57),0.0627,0.542
UMP Synthase Deiciency (Orotic Aciduria),SMPDB,4,C00064;C00178;C00429;C00475,57 (57),0.0627,0.542
MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),SMPDB,4,C00064;C00178;C00429;C00475,57 (57),0.0627,0.542
Beta Ureidopropionase Deficiency,SMPDB,4,C00064;C00178;C00429;C00475,57 (57),0.0627,0.542
Dihydropyrimidinase Deficiency,SMPDB,4,C00064;C00178;C00429;C00475,57 (57),0.0627,0.542
Vitamin B9 (folate) metabolism,EHMN,3,C00065;C00025;C00080,35 (35),0.0638,0.542
cysteine biosynthesis,HumanCyc,2,C00065;C00109,16 (16),0.0653,0.542
isoleucine degradation,HumanCyc,2,C00025;C00080,16 (16),0.0653,0.542
Beta-oxidation of pristanoyl-CoA,Reactome,2,C00033;C00080,16 (22),0.0653,0.542
Oxidative phosphorylation - Homo sapiens (human),KEGG,2,C00080;C00122,16 (16),0.0653,0.542
Fructose catabolism,Reactome,2,C00258;C00080,16 (16),0.0653,0.542
superpathway of choline degradation to L-serine,HumanCyc,2,C00065;C00080,16 (16),0.0653,0.542
(S)-reticuline biosynthesis,HumanCyc,2,C00025;C00080,16 (16),0.0653,0.542
Aflatoxin activation and detoxification,Wikipathways,2,C00033;C00080,16 (29),0.0653,0.542
Ethanol effects on histone modifications,Wikipathways,2,C00033;C00065,16 (21),0.0653,0.542
3-Methylglutaconic Aciduria Type I,SMPDB,4,C06002;C00164;C00080;C00025,58 (58),0.066,0.542
Valine_ Leucine and Isoleucine Degradation,SMPDB,4,C06002;C00164;C00080;C00025,58 (58),0.066,0.542
2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,SMPDB,4,C06002;C00164;C00080;C00025,58 (58),0.066,0.542
Isovaleric Aciduria,SMPDB,4,C06002;C00164;C00080;C00025,58 (58),0.066,0.542
3-Methylcrotonyl Coa Carboxylase Deficiency Type I,SMPDB,4,C06002;C00164;C00080;C00025,58 (58),0.066,0.542
Propionic Acidemia,SMPDB,4,C06002;C00164;C00080;C00025,58 (58),0.066,0.542
Maple Syrup Urine Disease,SMPDB,4,C06002;C00164;C00080;C00025,58 (58),0.066,0.542
3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency,SMPDB,4,C06002;C00164;C00080;C00025,58 (58),0.066,0.542
Isobutyryl-coa dehydrogenase deficiency,SMPDB,4,C06002;C00164;C00080;C00025,58 (58),0.066,0.542
3-hydroxyisobutyric aciduria,SMPDB,4,C06002;C00164;C00080;C00025,58 (58),0.066,0.542
3-hydroxyisobutyric acid dehydrogenase deficiency,SMPDB,4,C06002;C00164;C00080;C00025,58 (58),0.066,0.542
Isovaleric acidemia,SMPDB,4,C06002;C00164;C00080;C00025,58 (58),0.066,0.542
Methylmalonate Semialdehyde Dehydrogenase Deficiency,SMPDB,4,C06002;C00164;C00080;C00025,58 (58),0.066,0.542
Methylmalonic Aciduria,SMPDB,4,C06002;C00164;C00080;C00025,58 (58),0.066,0.542
3-Methylglutaconic Aciduria Type IV,SMPDB,4,C06002;C00164;C00080;C00025,58 (58),0.066,0.542
3-Methylglutaconic Aciduria Type III,SMPDB,4,C06002;C00164;C00080;C00025,58 (58),0.066,0.542
Beta-Ketothiolase Deficiency,SMPDB,4,C06002;C00164;C00080;C00025,58 (58),0.066,0.542
Metabolism of vitamins and cofactors,Reactome,7,C00064;C00163;C00033;C00022;C00153;C00025;C00080,136 (180),0.0671,0.55
Mercaptopurine Action Pathway,SMPDB,5,C00064;C05512;C00049;C00025;C00122,83 (84),0.0674,0.551
Lysine degradation,INOH,3,C03793;C00025;C00449,36 (36),0.0684,0.558
Thioguanine Action Pathway,SMPDB,5,C00064;C05512;C00049;C00025;C00122,84 (85),0.0702,0.572
4-hydroxybenzoate biosynthesis,HumanCyc,2,C00025;C00080,17 (17),0.0728,0.585
mevalonate pathway,HumanCyc,2,C00418;C00080,17 (17),0.0728,0.585
Pyruvate Carboxylase Deficiency,SMPDB,2,C00022;C00025,17 (17),0.0728,0.585
Primary Hyperoxaluria Type I,SMPDB,2,C00022;C00025,17 (17),0.0728,0.585
Mitochondrial Electron Transport Chain,SMPDB,2,C00080;C00122,17 (17),0.0728,0.585
Lactic Acidemia,SMPDB,2,C00022;C00025,17 (17),0.0728,0.585
Alanine Metabolism,SMPDB,2,C00022;C00025,17 (17),0.0728,0.585
Azathioprine Action Pathway,SMPDB,5,C00064;C05512;C00049;C00025;C00122,85 (86),0.0731,0.587
Type 2 papillary renal cell carcinoma,Wikipathways,1,C00122,3 (3),0.0772,0.6
Trafficking and processing of endosomal TLR,Reactome,1,C00080,3 (3),0.0772,0.6
Activation of Na-permeable kainate receptors,Reactome,1,C00025,3 (3),0.0772,0.6
Activation of Ca-permeable Kainate Receptor,Reactome,1,C00025,3 (3),0.0772,0.6
Reduction of cytosolic Ca++ levels,Reactome,1,C00080,3 (3),0.0772,0.6
Osteoclast Signaling,Wikipathways,1,C00080,3 (4),0.0772,0.6
The fatty acid cycling model,Reactome,1,C00080,3 (3),0.0772,0.6
Inositol transporters,Reactome,1,C00080,3 (4),0.0772,0.6
Huntington disease - Homo sapiens (human),KEGG,1,C00025,3 (3),0.0772,0.6
<i>N</i>-acetylglucosamine degradation I,HumanCyc,1,C00033,3 (5),0.0772,0.6
Renal cell carcinoma - Homo sapiens (human),KEGG,1,C00122,3 (3),0.0772,0.6
Influenza A - Homo sapiens (human),KEGG,1,C00080,3 (3),0.0772,0.6
dermatan sulfate biosynthesis (late stages),HumanCyc,1,C00080,3 (3),0.0772,0.6
chondroitin and dermatan biosynthesis,HumanCyc,1,C00080,3 (4),0.0772,0.6
Activation of AMPA receptors,Reactome,1,C00025,3 (3),0.0772,0.6
Sterol Regulatory Element-Binding Proteins (SREBP) signalling,Wikipathways,1,C00064,3 (5),0.0772,0.6
Trafficking and processing of endosomal TLR,Wikipathways,1,C00080,3 (3),0.0772,0.6
Mitochondrial calcium ion transport,Wikipathways,1,C00080,3 (3),0.0772,0.6
Glutathione metabolism - Homo sapiens (human),KEGG,3,C00077;C01879;C00025,38 (38),0.0778,0.602
Selenoamino acid metabolism,EHMN,3,C00065;C00109;C00080,38 (38),0.0778,0.602
Biosynthesis of DHA-derived SPMs,Reactome,2,C00025;C00080,18 (72),0.0805,0.617
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,Reactome,2,C00178;C00475,18 (18),0.0805,0.617
superpathway of melatonin degradation,HumanCyc,2,C00033;C00080,18 (24),0.0805,0.617
Spermidine and Spermine Biosynthesis,SMPDB,2,C00077;C00080,18 (18),0.0805,0.617
Ethanol Degradation,SMPDB,2,C00033;C00080,18 (18),0.0805,0.617
DNA Repair,Reactome,3,C00153;C00429;C00178,40 (48),0.0878,0.667
Valine Leucine Isoleucine degradation,INOH,3,C00164;C06002;C00025,40 (40),0.0878,0.667
Glycosaminoglycan metabolism,Reactome,3,C00033;C00049;C00080,40 (60),0.0878,0.667
Branched-chain amino acid catabolism,Wikipathways,3,C00349;C03793;C00080,40 (46),0.0878,0.667
Glucose metabolism,Wikipathways,3,C00022;C00074;C00080,40 (43),0.0878,0.667
Threonine and 2-Oxobutanoate Degradation,SMPDB,2,C00109;C00188,19 (19),0.0884,0.667
Nitrogen metabolism - Homo sapiens (human),KEGG,2,C00064;C00025,19 (19),0.0884,0.667
Fatty Acid Biosynthesis,SMPDB,2,C00033;C00164,19 (31),0.0884,0.667
Glutathione metabolism,Wikipathways,2,C00025;C01879,19 (19),0.0884,0.667
Cystathionine Beta-Synthase Deficiency,SMPDB,3,C00065;C00263;C00109,41 (42),0.093,0.692
S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,SMPDB,3,C00065;C00263;C00109,41 (42),0.093,0.692
Methionine Metabolism,SMPDB,3,C00065;C00263;C00109,41 (42),0.093,0.692
Methionine Adenosyltransferase Deficiency,SMPDB,3,C00065;C00263;C00109,41 (42),0.093,0.692
Glycine N-methyltransferase Deficiency,SMPDB,3,C00065;C00263;C00109,41 (42),0.093,0.692
Hypermethioninemia,SMPDB,3,C00065;C00263;C00109,41 (42),0.093,0.692
Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),SMPDB,3,C00065;C00263;C00109,41 (42),0.093,0.692
Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism_ cblG complementation type,SMPDB,3,C00065;C00263;C00109,41 (42),0.093,0.692
Metabolism of folate and pterines,Reactome,2,C00025;C00080,20 (25),0.0966,0.715
Carnitine Synthesis,SMPDB,2,C03793;C00080,20 (20),0.0966,0.715
Fructose metabolism,Wikipathways,2,C00258;C00080,20 (20),0.0966,0.715
Valine_ leucine and isoleucine degradation - Homo sapiens (human),KEGG,3,C00349;C00164;C06002,42 (42),0.0983,0.726
GPCR ligand binding,Reactome,6,C00077;C00163;C00388;C00033;C00025;C00080,121 (141),0.0995,0.727
thio-molybdenum cofactor biosynthesis,HumanCyc,1,C00080,4 (6),0.102,0.727
Ionotropic activity of kainate receptors,Reactome,1,C00025,4 (4),0.102,0.727
Activation of kainate receptors upon glutamate binding,Reactome,1,C00025,4 (4),0.102,0.727
Type II diabetes mellitus,Wikipathways,1,C00022,4 (4),0.102,0.727
Biosynthesis of maresin conjugates in tissue regeneration (MCTR),Reactome,1,C00025,4 (8),0.102,0.727
Bicarbonate transporters,Reactome,1,C00080,4 (4),0.102,0.727
Downregulation of SMAD2/3:SMAD4 transcriptional activity,Reactome,1,C00153,4 (4),0.102,0.727
Cardiac muscle contraction - Homo sapiens (human),KEGG,1,C00080,4 (4),0.102,0.727
Rheumatoid arthritis - Homo sapiens (human),KEGG,1,C00080,4 (4),0.102,0.727
Metabolism of vitamin K,Reactome,1,C00080,4 (6),0.102,0.727
glycine biosynthesis,HumanCyc,1,C00022,4 (4),0.102,0.727
chondroitin sulfate biosynthesis (late stages),HumanCyc,1,C00080,4 (5),0.102,0.727
Sperm Motility And Taxes,Reactome,1,C00080,4 (4),0.102,0.727
Mitochondrial calcium ion transport,Reactome,1,C00080,4 (4),0.102,0.727
Prednisone Metabolism Pathway,SMPDB,1,C00080,4 (4),0.102,0.727
Prednisone Action Pathway,SMPDB,1,C00080,4 (4),0.102,0.727
thioredoxin pathway,HumanCyc,1,C00080,4 (4),0.102,0.727
SIRT1 negatively regulates rRNA expression,Wikipathways,1,C00153,4 (5),0.102,0.727
Fructose metabolism,Reactome,2,C00258;C00080,21 (21),0.105,0.745
Synthesis of Leukotrienes (LT) and Eoxins (EX),Reactome,2,C00025;C00080,21 (28),0.105,0.745
superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate),HumanCyc,2,C00418;C00080,21 (21),0.105,0.745
folate transformations,HumanCyc,2,C00065;C00080,21 (21),0.105,0.745
lysine degradation II (pipecolate pathway),HumanCyc,2,C00025;C00080,21 (21),0.105,0.745
Tyrosine metabolism,INOH,3,C00122;C00164;C00025,44 (44),0.109,0.774
tryptophan degradation,HumanCyc,2,C02220;C00080,22 (22),0.114,0.788
TCA cycle,HumanCyc,2,C00080;C00122,22 (23),0.114,0.788
Free fatty acid receptors,Reactome,2,C00033;C00163,22 (24),0.114,0.788
Transfer of Acetyl Groups into Mitochondria,SMPDB,2,C00022;C00080,22 (22),0.114,0.788
Gamma-glutamyl-transpeptidase deficiency,SMPDB,2,C01879;C00025,22 (22),0.114,0.788
5-oxoprolinase deficiency,SMPDB,2,C01879;C00025,22 (22),0.114,0.788
Gamma-Glutamyltransferase Deficiency,SMPDB,2,C01879;C00025,22 (22),0.114,0.788
Glutathione Metabolism,SMPDB,2,C01879;C00025,22 (22),0.114,0.788
Ifosfamide Action Pathway,SMPDB,2,C01471;C00080,22 (22),0.114,0.788
Glutathione Synthetase Deficiency,SMPDB,2,C01879;C00025,22 (22),0.114,0.788
Ifosfamide Metabolism Pathway,SMPDB,2,C01471;C00080,22 (22),0.114,0.788
5-Oxoprolinuria,SMPDB,2,C01879;C00025,22 (22),0.114,0.788
NAD Biosynthesis II (from tryptophan),Wikipathways,2,C00064;C00025,22 (23),0.114,0.788
Asparagine N-linked glycosylation,Reactome,5,C00064;C00022;C00074;C00025;C00080,98 (119),0.116,0.805
Methionine De Novo and Salvage Pathway,Wikipathways,3,C00077;C00022;C00025,46 (47),0.121,0.805
Developmental Biology,Reactome,2,C00025;C00080,23 (26),0.122,0.805
Butanoate metabolism,INOH,2,C00033;C00164,23 (23),0.122,0.805
Pyrimidine salvage,Reactome,2,C00475;C00178,23 (23),0.122,0.805
Cyclophosphamide Action Pathway,SMPDB,2,C01471;C00080,23 (23),0.122,0.805
Cyclophosphamide Metabolism Pathway,SMPDB,2,C01471;C00080,23 (23),0.122,0.805
glycine/serine biosynthesis,HumanCyc,1,C00065,5 (5),0.125,0.805
OAS antiviral response,Wikipathways,1,C00080,5 (5),0.125,0.805
Oxidative phosphorylation,Wikipathways,1,C00080,5 (5),0.125,0.805
Amino acid conjugation,Wikipathways,1,C00064,5 (6),0.125,0.805
SIRT1 negatively regulates rRNA expression,Reactome,1,C00153,5 (6),0.125,0.805
bupropion degradation,HumanCyc,1,C00080,5 (10),0.125,0.805
HDR through MMEJ (alt-NHEJ),Reactome,1,C00153,5 (5),0.125,0.805
RUNX3 regulates p14-ARF,Reactome,1,C00033,5 (5),0.125,0.805
cardiolipin biosynthesis,HumanCyc,1,C00080,5 (9),0.125,0.805
Regulation of PTEN stability and activity,Reactome,1,C00153,5 (5),0.125,0.805
fatty acid elongation -- saturated,HumanCyc,1,C00080,5 (5),0.125,0.805
Cytosolic iron-sulfur cluster assembly,Reactome,1,C00080,5 (8),0.125,0.805
Formation of ATP by chemiosmotic coupling,Reactome,1,C00080,5 (5),0.125,0.805
Electron transport from NADPH to Ferredoxin,Reactome,1,C00080,5 (7),0.125,0.805
thiamin salvage III,HumanCyc,1,C00080,5 (5),0.125,0.805
hypoxia-inducible factor in the cardivascular system,BioCarta,1,C00022,5 (5),0.125,0.805
Asthma - Homo sapiens (human),KEGG,1,C00388,5 (5),0.125,0.805
FoxO signaling pathway - Homo sapiens (human),KEGG,1,C00025,5 (5),0.125,0.805
Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate,Reactome,1,C00080,5 (5),0.125,0.805
Diseases of metabolism,Reactome,1,C00080,5 (5),0.125,0.805
adenine and adenosine salvage II,HumanCyc,1,C00080,5 (5),0.125,0.805
sorbitol degradation I,HumanCyc,1,C00080,5 (5),0.125,0.805
progesterone biosynthesis,HumanCyc,1,C00080,5 (6),0.125,0.805
PRPP biosynthesis,HumanCyc,1,C00080,5 (6),0.125,0.805
glycoaminoglycan-protein linkage region biosynthesis,HumanCyc,1,C00080,5 (5),0.125,0.805
Cross-presentation of particulate exogenous antigens (phagosomes),Reactome,1,C00080,5 (5),0.125,0.805
Reversible hydration of carbon dioxide,Reactome,1,C00080,5 (5),0.125,0.805
thiosulfate disproportionation III (rhodanese),HumanCyc,1,C00080,5 (5),0.125,0.805
Ras activation upon Ca2+ influx through NMDA receptor,Reactome,1,C00025,5 (5),0.125,0.805
Unblocking of NMDA receptor_ glutamate binding and activation,Reactome,1,C00025,5 (5),0.125,0.805
CREB phosphorylation through the activation of CaMKII,Reactome,1,C00025,5 (5),0.125,0.805
protein <i>O</i>-[<i>N</i>-acetyl]-glucosylation,HumanCyc,1,C00080,5 (5),0.125,0.805
Heroin Metabolism Pathway,SMPDB,1,C00033,5 (5),0.125,0.805
thyroid hormone metabolism I (via deiodination),HumanCyc,1,C00080,5 (11),0.125,0.805
Neurotoxicity of clostridium toxins,Wikipathways,1,C00080,5 (6),0.125,0.805
hypusine biosynthesis,HumanCyc,1,C00080,5 (5),0.125,0.805
Fertilization,Wikipathways,1,C00080,5 (5),0.125,0.805
Reversible hydration of carbon dioxide,Wikipathways,1,C00080,5 (5),0.125,0.805
Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate,Wikipathways,1,C00080,5 (5),0.125,0.805
HDR through MMEJ (alt-NHEJ),Wikipathways,1,C00153,5 (5),0.125,0.805
Glucose Alanine cycle,Wikipathways,1,C00022,5 (5),0.125,0.805
glutathione redox reactions II,HumanCyc,1,C00080,5 (5),0.125,0.805
Metabolism of proteins,Reactome,9,C00064;C00148;C00033;C00022;C00025;C00074;C00080;C00049;C00135,220 (269),0.126,0.807
Interconversion of nucleotide di- and triphosphates,Reactome,3,C00064;C00025;C00080,47 (52),0.127,0.809
Inositol phosphate metabolism - Homo sapiens (human),KEGG,3,C00222;C03660;C03659,47 (47),0.127,0.809
Class A/1 (Rhodopsin-like receptors),Reactome,4,C00033;C00163;C00388;C00080,74 (82),0.131,0.831
Heparan sulfate/heparin (HS-GAG) metabolism,Reactome,2,C00033;C00049,24 (35),0.131,0.831
Neurotransmitter clearance,Reactome,2,C00033;C00080,24 (24),0.131,0.831
Glycolysis,SMPDB,2,C00022;C00074,24 (24),0.131,0.831
Glycogenosis_ Type VII. Tarui disease,SMPDB,2,C00022;C00074,24 (24),0.131,0.831
Fanconi-bickel syndrome,SMPDB,2,C00022;C00074,24 (24),0.131,0.831
Neurotransmitter clearance,Wikipathways,2,C00033;C00080,24 (24),0.131,0.831
Disorders of Folate Metabolism and Transport,Wikipathways,2,C00025;C00135,25 (26),0.14,0.875
Glutaric Aciduria Type I,SMPDB,2,C00025;C00449,25 (27),0.14,0.875
Pyruvate metabolism,Reactome,2,C00022;C00080,25 (25),0.14,0.875
Lysine Degradation,SMPDB,2,C00025;C00449,25 (27),0.14,0.875
Hyperlysinemia I_ Familial,SMPDB,2,C00025;C00449,25 (27),0.14,0.875
2-aminoadipic 2-oxoadipic aciduria,SMPDB,2,C00025;C00449,25 (27),0.14,0.875
Pyridoxine dependency with seizures,SMPDB,2,C00025;C00449,25 (27),0.14,0.875
Saccharopinuria/Hyperlysinemia II,SMPDB,2,C00025;C00449,25 (27),0.14,0.875
Hyperlysinemia II or Saccharopinuria,SMPDB,2,C00025;C00449,25 (27),0.14,0.875
Platelet homeostasis,Wikipathways,2,C00033;C00080,25 (28),0.14,0.875
Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs),Wikipathways,1,C00080,6 (8),0.149,0.881
lipoate salvage,HumanCyc,1,C00080,6 (6),0.149,0.881
oxidized GTP and dGTP detoxification,HumanCyc,1,C00080,6 (10),0.149,0.881
glycogen biosynthesis,HumanCyc,1,C00080,6 (7),0.149,0.881
Regulation of HSF1-mediated heat shock response,Reactome,1,C00153,6 (7),0.149,0.881
retinoate biosynthesis I,HumanCyc,1,C00080,6 (6),0.149,0.881
Synthesis and degradation of ketone bodies - Homo sapiens (human),KEGG,1,C00164,6 (6),0.149,0.881
Biosynthesis of protectins,Reactome,1,C00080,6 (14),0.149,0.881
Biosynthesis of maresin-like SPMs,Reactome,1,C00080,6 (15),0.149,0.881
The proton buffering model,Reactome,1,C00080,6 (6),0.149,0.881
Type II diabetes mellitus - Homo sapiens (human),KEGG,1,C00022,6 (6),0.149,0.881
POLB-Dependent Long Patch Base Excision Repair,Reactome,1,C00153,6 (6),0.149,0.881
Resolution of AP sites via the multiple-nucleotide patch replacement pathway,Reactome,1,C00153,6 (6),0.149,0.881
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,Reactome,1,C00153,6 (6),0.149,0.881
D-<i>myo</i>-inositol-5-phosphate metabolism,HumanCyc,1,C00080,6 (8),0.149,0.881
acetate conversion to acetyl-CoA,HumanCyc,1,C00033,6 (6),0.149,0.881
Reuptake of GABA,Reactome,1,C03283,6 (6),0.149,0.881
thyroid hormone biosynthesis,HumanCyc,1,C00080,6 (6),0.149,0.881
melatonin degradation III,HumanCyc,1,C00080,6 (7),0.149,0.881
dolichyl-diphosphooligosaccharide biosynthesis,HumanCyc,1,C00080,6 (7),0.149,0.881
&alpha;-tocopherol degradation,HumanCyc,1,C00080,6 (9),0.149,0.881
Transcriptional activation of mitochondrial biogenesis,Reactome,1,C00153,6 (7),0.149,0.881
Regulation of thyroid hormone activity,Reactome,1,C00080,6 (6),0.149,0.881
GDP-L-fucose biosynthesis I (from GDP-D-mannose),HumanCyc,1,C00080,6 (7),0.149,0.881
retinoate biosynthesis II,HumanCyc,1,C00080,6 (6),0.149,0.881
D4&E4-neuroprostanes formation,EHMN,1,C00080,6 (6),0.149,0.881
Signaling by Insulin receptor,Wikipathways,1,C00080,6 (6),0.149,0.881
Transcriptional activity of SMAD2-SMAD3-SMAD4 heterotrimer,Wikipathways,1,C00153,6 (6),0.149,0.881
Synaptic Vesicle Pathway,Wikipathways,1,C00064,6 (7),0.149,0.881
Digestion resistant carbohydrate metabolism,Wikipathways,1,C00033,6 (6),0.149,0.881
fructose 2_6-bisphosphate synthesis,HumanCyc,1,C00080,6 (7),0.149,0.881
aspirin-triggered lipoxin biosynthesis,HumanCyc,1,C00080,6 (9),0.149,0.881
Uptake and function of anthrax toxins,Wikipathways,1,C00080,6 (6),0.149,0.881
NADPH regeneration,Wikipathways,1,C00080,6 (6),0.149,0.881
Post-translational protein modification,Reactome,6,C00064;C00074;C00033;C00022;C00025;C00080,136 (176),0.149,0.881
Organic cation transport,Reactome,2,C00388;C00080,26 (29),0.15,0.881
Beta-mercaptolactate-cysteine disulfiduria,SMPDB,2,C00022;C00025,26 (26),0.15,0.881
Cysteine Metabolism,SMPDB,2,C00022;C00025,26 (26),0.15,0.881
Cystinosis_ ocular nonnephropathic,SMPDB,2,C00022;C00025,26 (26),0.15,0.881
Platelet homeostasis,Reactome,2,C00033;C00080,26 (28),0.15,0.881
morphine biosynthesis,HumanCyc,2,C00033;C00080,27 (27),0.159,0.925
Carbohydrate digestion and absorption - Homo sapiens (human),KEGG,2,C00033;C00163,27 (27),0.159,0.925
Sulfur amino acid metabolism,Wikipathways,3,C00022;C00109;C00080,53 (67),0.164,0.925
Vitamin B6 metabolism - Homo sapiens (human),KEGG,2,C00266;C00232,28 (28),0.168,0.925
Signaling by Retinoic Acid,Reactome,2,C00022;C00080,28 (29),0.168,0.925
Folate malabsorption_ hereditary,SMPDB,2,C00025;C00080,28 (28),0.168,0.925
Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),SMPDB,2,C00025;C00080,28 (28),0.168,0.925
Folate Metabolism,SMPDB,2,C00025;C00080,28 (28),0.168,0.925
Selenoamino Acid Metabolism,SMPDB,2,C00065;C00109,28 (28),0.168,0.925
Monoamine GPCRs,Wikipathways,1,C00388,7 (7),0.171,0.925
glutamate removal from folates,HumanCyc,1,C00025,7 (7),0.171,0.925
GDP-mannose biosynthesis,HumanCyc,1,C00080,7 (8),0.171,0.925
spermidine biosynthesis,HumanCyc,1,C00080,7 (7),0.171,0.925
mRNA capping,HumanCyc,1,C00080,7 (7),0.171,0.925
Transcriptional regulation by RUNX3,Reactome,1,C00033,7 (7),0.171,0.925
NAD phosphorylation and dephosphorylation,HumanCyc,1,C00080,7 (7),0.171,0.925
spermine biosynthesis,HumanCyc,1,C00080,7 (7),0.171,0.925
Transport and synthesis of PAPS,Reactome,1,C00080,7 (7),0.171,0.925
2-oxoisovalerate decarboxylation to isobutanoyl-CoA,HumanCyc,1,C00080,7 (7),0.171,0.925
choline degradation,HumanCyc,1,C00080,7 (7),0.171,0.925
Fertilization,Reactome,1,C00080,7 (7),0.171,0.925
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),Reactome,1,C00080,7 (11),0.171,0.925
Signaling by TGF-beta Receptor Complex,Reactome,1,C00153,7 (7),0.171,0.925
GDP-L-fucose biosynthesis II (from L-fucose),HumanCyc,1,C00080,7 (8),0.171,0.925
Mitochondrial iron-sulfur cluster biogenesis,Reactome,1,C00080,7 (11),0.171,0.925
Biosynthesis of maresins,Reactome,1,C00080,7 (21),0.171,0.925
Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR),Reactome,1,C00025,7 (17),0.171,0.925
Biosynthesis of DHA-derived sulfido conjugates,Reactome,1,C00025,7 (21),0.171,0.925
Glycosaminoglycan biosynthesis - heparan sulfate / heparin - Homo sapiens (human),KEGG,1,C00033,7 (7),0.171,0.925
Rapoport-Luebering glycolytic shunt,HumanCyc,1,C00080,7 (7),0.171,0.925
Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human),KEGG,1,C00080,7 (7),0.171,0.925
2_-deoxy-&alpha;-D-ribose 1-phosphate degradation,HumanCyc,1,C00080,7 (8),0.171,0.925
Nicotine addiction - Homo sapiens (human),KEGG,1,C00025,7 (7),0.171,0.925
Metabolism of ingested MeSeO2H into MeSeH,Reactome,1,C00080,7 (8),0.171,0.925
NADPH regeneration,Reactome,1,C00080,7 (7),0.171,0.925
Carboxyterminal post-translational modifications of tubulin,Reactome,1,C00025,7 (9),0.171,0.925
tetrahydrofolate salvage from 5_10-methenyltetrahydrofolate,HumanCyc,1,C00080,7 (7),0.171,0.925
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,Reactome,1,C00080,7 (7),0.171,0.925
Long-term potentiation - Homo sapiens (human),KEGG,1,C00025,7 (7),0.171,0.925
inositol pyrophosphates biosynthesis,HumanCyc,1,C00080,7 (10),0.171,0.925
UDP-D-xylose and UDP-D-glucuronate biosynthesis,HumanCyc,1,C00080,7 (8),0.171,0.925
putrescine biosynthesis II,HumanCyc,1,C00080,7 (7),0.171,0.925
Arachidonate production from DAG,Reactome,1,C00080,7 (8),0.171,0.925
sulfate activation for sulfonation,HumanCyc,1,C00080,7 (7),0.171,0.925
chondroitin sulfate biosynthesis,HumanCyc,1,C00080,7 (8),0.171,0.925
Acetylcholine Neurotransmitter Release Cycle,Reactome,1,C00080,7 (7),0.171,0.925
Metal ion SLC transporters,Reactome,1,C00080,7 (7),0.171,0.925
2-oxoglutarate decarboxylation to succinyl-CoA,HumanCyc,1,C00080,7 (7),0.171,0.925
flavin biosynthesis,HumanCyc,1,C00080,7 (7),0.171,0.925
NADH repair,HumanCyc,1,C00080,7 (8),0.171,0.925
glycerol-3-phosphate shuttle,HumanCyc,1,C00080,7 (9),0.171,0.925
CREB phosphorylation through the activation of Ras,Reactome,1,C00025,7 (7),0.171,0.925
mucin core 1 and core 2 <i>O</i>-glycosylation,HumanCyc,1,C00080,7 (8),0.171,0.925
dermatan sulfate biosynthesis,HumanCyc,1,C00080,7 (8),0.171,0.925
Desipramine Metabolism Pathway,SMPDB,1,C00080,7 (7),0.171,0.925
Mitochondrial biogenesis,Reactome,1,C00153,7 (8),0.171,0.925
oleate biosynthesis,HumanCyc,1,C00080,7 (7),0.171,0.925
Platelet calcium homeostasis,Reactome,1,C00080,7 (7),0.171,0.925
Signaling by TGF-beta family members,Reactome,1,C00153,7 (7),0.171,0.925
Mitochondrial iron-sulfur cluster biogenesis,Wikipathways,1,C00080,7 (13),0.171,0.925
NoRC negatively regulates rRNA expression,Wikipathways,1,C00033,7 (7),0.171,0.925
DNA Damage-Telomere Stress Induced Senescence,Wikipathways,1,C00080,7 (9),0.171,0.925
nicotine degradation III,HumanCyc,1,C00080,7 (23),0.171,0.925
Transcriptional regulation by RUNX3,Wikipathways,1,C00033,7 (7),0.171,0.925
PI3K-AKT-mTOR - VitD3 Signalling,Wikipathways,1,C00022,7 (8),0.171,0.925
Pentose and glucuronate interconversions - Homo sapiens (human),KEGG,3,C00266;C00022;C00433,55 (55),0.177,0.955
Signaling by Retinoic Acid,Wikipathways,2,C00022;C00080,29 (31),0.178,0.956
Biosynthesis of specialized proresolving mediators (SPMs),Reactome,2,C00025;C00080,29 (140),0.178,0.956
Methotrexate Action Pathway,SMPDB,2,C00025;C00080,29 (29),0.178,0.956
Purine salvage,Reactome,2,C05512;C00080,30 (31),0.187,0.976
Keratinization,Reactome,1,C00080,8 (9),0.193,0.976
COX reactions,Reactome,1,C00080,8 (8),0.193,0.976
trehalose degradation,HumanCyc,1,C00080,8 (8),0.193,0.976
eumelanin biosynthesis,HumanCyc,1,C00080,8 (9),0.193,0.976
1D-<i>myo</i>-inositol hexakisphosphate biosynthesis V (from Ins(1_3_4)P3),HumanCyc,1,C00080,8 (8),0.193,0.976
Transferrin endocytosis and recycling,Reactome,1,C00080,8 (8),0.193,0.976
Conjugation of phenylacetate with glutamine,Reactome,1,C00064,8 (8),0.193,0.976
allopregnanolone biosynthesis,HumanCyc,1,C00080,8 (8),0.193,0.976
Influenza Life Cycle,Reactome,1,C00080,8 (9),0.193,0.976
estradiol biosynthesis II,HumanCyc,1,C00080,8 (8),0.193,0.976
Influenza Infection,Reactome,1,C00080,8 (9),0.193,0.976
D-<i>myo</i>-inositol (1_3_4)-trisphosphate biosynthesis,HumanCyc,1,C00080,8 (8),0.193,0.976
Sterols are 12-hydroxylated by CYP8B1,Reactome,1,C00080,8 (10),0.193,0.976
Hypusine synthesis from eIF5A-lysine,Reactome,1,C00080,8 (8),0.193,0.976
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids,Reactome,1,C00080,8 (11),0.193,0.976
glycine cleavage,HumanCyc,1,C00080,8 (8),0.193,0.976
Global Genome Nucleotide Excision Repair (GG-NER),Reactome,1,C00153,8 (8),0.193,0.976
3-phosphoinositide biosynthesis,HumanCyc,1,C00080,8 (11),0.193,0.976
D-<i>myo</i>-inositol (1_4_5)-trisphosphate biosynthesis,HumanCyc,1,C00080,8 (13),0.193,0.976
Mitochondrial Uncoupling Proteins,Reactome,1,C00080,8 (8),0.193,0.976
Collecting duct acid secretion - Homo sapiens (human),KEGG,1,C00080,8 (8),0.193,0.976
Cocaine addiction - Homo sapiens (human),KEGG,1,C00025,8 (8),0.193,0.976
Amine ligand-binding receptors,Reactome,1,C00388,8 (8),0.193,0.976
Erythrocytes take up oxygen and release carbon dioxide,Reactome,1,C00080,8 (8),0.193,0.976
Cysteine formation from homocysteine,Reactome,1,C00109,8 (9),0.193,0.976
Resolution of Abasic Sites (AP sites),Reactome,1,C00153,8 (8),0.193,0.976
lipoate biosynthesis and incorporation,HumanCyc,1,C00080,8 (8),0.193,0.976
Processing of DNA double-strand break ends,Reactome,1,C00153,8 (9),0.193,0.976
Cellular response to heat stress,Reactome,1,C00153,8 (9),0.193,0.976
Mtb iron assimilation by chelation,Reactome,1,C00080,8 (11),0.193,0.976
Glutamate binding_ activation of AMPA receptors and synaptic plasticity,Reactome,1,C00025,8 (8),0.193,0.976
L-dopachrome biosynthesis,HumanCyc,1,C00080,8 (8),0.193,0.976
Intracellular Signalling Through Histamine H2 Receptor and Histamine,SMPDB,1,C00388,8 (8),0.193,0.976
terminal <i>O</i>-glycans residues modification,HumanCyc,1,C00080,8 (9),0.193,0.976
methionine salvage,HumanCyc,1,C00080,8 (8),0.193,0.976
Prostaglandin formation from dihomo gama-linoleic acid,EHMN,1,C00080,8 (8),0.193,0.976
thyroid hormone metabolism II (via conjugation and/or degradation),HumanCyc,1,C00080,8 (22),0.193,0.976
PDGF Pathway,Wikipathways,1,C00080,8 (8),0.193,0.976
Erythrocytes take up oxygen and release carbon dioxide,Wikipathways,1,C00080,8 (8),0.193,0.976
Influenza Life Cycle,Wikipathways,1,C00080,8 (9),0.193,0.976
glycerol degradation,HumanCyc,1,C00080,8 (10),0.193,0.976
Formation of the cornified envelope,Reactome,1,C00080,8 (9),0.193,0.976
Resolution of Abasic Sites (AP sites),Wikipathways,1,C00153,8 (9),0.193,0.976
Cellular response to heat stress,Wikipathways,1,C00153,8 (9),0.193,0.976
Amyloid fiber formation,Wikipathways,1,C00033,8 (8),0.193,0.976
Fatty Acid Biosynthesis,Wikipathways,1,C00022,8 (9),0.193,0.976
Tolerance of reactive oxygen produced by macrophages,Reactome,1,C00080,8 (8),0.193,0.976
Cell redox homeostasis,Reactome,1,C00080,8 (8),0.193,0.976
Nucleotide Excision Repair,Reactome,1,C00153,8 (8),0.193,0.976
Keratinization,Wikipathways,1,C00080,8 (9),0.193,0.976
Pentose phosphate cycle,INOH,2,C00064;C00025,31 (31),0.197,0.994
Signaling by Nuclear Receptors,Reactome,2,C00022;C00080,32 (36),0.207,1
Phase II - Conjugation of compounds,Reactome,5,C00064;C14856;C01879;C00080;C00025,120 (148),0.21,1
Biological oxidations,Reactome,9,C05665;C00064;C05130;C00033;C00025;C14856;C00080;C01879;C00388,249 (321),0.211,1
Biosynthesis of electrophilic -3 PUFA oxo-derivatives,Wikipathways,1,C00080,9 (27),0.214,1
GPCRs_ Class A Rhodopsin-like,Wikipathways,1,C00388,9 (10),0.214,1
Homology Directed Repair,Reactome,1,C00153,9 (10),0.214,1
HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA),Reactome,1,C00153,9 (10),0.214,1
HS-GAG biosynthesis,Reactome,1,C00033,9 (9),0.214,1
Glycine degradation,Reactome,1,C00080,9 (12),0.214,1
Biosynthesis of electrophilic ?-3 PUFA oxo-derivatives,Reactome,1,C00080,9 (27),0.214,1
EPHB-mediated forward signaling,Reactome,1,C00025,9 (9),0.214,1
EPH-Ephrin signaling,Reactome,1,C00025,9 (9),0.214,1
D-<i>myo</i>-inositol (1_4_5_6)-tetrakisphosphate biosynthesis,HumanCyc,1,C00080,9 (9),0.214,1
Long-term depression - Homo sapiens (human),KEGG,1,C00025,9 (9),0.214,1
Apelin signaling pathway - Homo sapiens (human),KEGG,1,C00080,9 (9),0.214,1
Vibrio cholerae infection - Homo sapiens (human),KEGG,1,C00080,9 (9),0.214,1
dolichol and dolichyl phosphate biosynthesis,HumanCyc,1,C00080,9 (10),0.214,1
glucocorticoid biosynthesis,HumanCyc,1,C00080,9 (9),0.214,1
Vitamin D (calciferol) metabolism,Reactome,1,C00080,9 (9),0.214,1
D-<i>myo</i>-inositol (3_4_5_6)-tetrakisphosphate biosynthesis,HumanCyc,1,C00080,9 (9),0.214,1
pentose phosphate pathway (oxidative branch),HumanCyc,1,C00080,9 (9),0.214,1
phosphatidylcholine biosynthesis,HumanCyc,1,C00080,9 (12),0.214,1
propionyl-CoA degradation,HumanCyc,1,C00080,9 (9),0.214,1
Regulation of TP53 Activity through Acetylation,Reactome,1,C00033,9 (9),0.214,1
diphthamide biosynthesis,HumanCyc,1,C00080,9 (9),0.214,1
Post NMDA receptor activation events,Reactome,1,C00025,9 (9),0.214,1
Rosiglitazone Metabolism Pathway,SMPDB,1,C00080,9 (10),0.214,1
Phenylacetate Metabolism,SMPDB,1,C00064,9 (9),0.214,1
fatty acid biosynthesis initiation,HumanCyc,1,C00080,9 (9),0.214,1
Nucleotide Excision Repair,Wikipathways,1,C00153,9 (9),0.214,1
phosphatidylethanolamine biosynthesis II,HumanCyc,1,C00080,9 (12),0.214,1
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),Wikipathways,1,C00153,9 (10),0.214,1
Regulation of TP53 Activity through Acetylation,Wikipathways,1,C00033,9 (9),0.214,1
Metabolism of vitamin K,Wikipathways,1,C00080,9 (11),0.214,1
Fructose Mannose metabolism,INOH,2,C00064;C00025,33 (33),0.216,1
Organic cation/anion/zwitterion transport,Reactome,2,C00388;C00080,33 (36),0.216,1
Class A-1 (Rhodopsin-like receptors),Wikipathways,4,C00033;C00163;C00388;C00080,92 (104),0.225,1
Ion influx/efflux at host-pathogen interface,Reactome,1,C00080,10 (11),0.235,1
Negative epigenetic regulation of rRNA expression,Reactome,1,C00153,10 (12),0.235,1
Formation of the active cofactor_ UDP-glucuronate,Reactome,1,C00080,10 (10),0.235,1
phenylalanine degradation/tyrosine biosynthesis,HumanCyc,1,C00080,10 (11),0.235,1
Fructose biosynthesis,Reactome,1,C00080,10 (10),0.235,1
1_25-dihydroxyvitamin D<sub>3</sub> biosynthesis,HumanCyc,1,C00080,10 (10),0.235,1
Vitamin C (ascorbate) metabolism,Reactome,1,C00080,10 (12),0.235,1
Protein repair,Reactome,1,C00049,10 (13),0.235,1
Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2,Reactome,1,C00080,10 (10),0.235,1
Uptake and actions of bacterial toxins,Reactome,1,C00153,10 (11),0.235,1
O2/CO2 exchange in erythrocytes,Reactome,1,C00080,10 (11),0.235,1
Ion homeostasis,Reactome,1,C00080,10 (10),0.235,1
Pregnenolone biosynthesis,Reactome,1,C00080,10 (13),0.235,1
Amyotrophic lateral sclerosis (ALS) - Homo sapiens (human),KEGG,1,C00025,10 (10),0.235,1
Alcoholism - Homo sapiens (human),KEGG,1,C00025,10 (10),0.235,1
Amphetamine addiction - Homo sapiens (human),KEGG,1,C00025,10 (10),0.235,1
Estrogen biosynthesis,Reactome,1,C00080,10 (10),0.235,1
Cardiac conduction,Reactome,1,C00080,10 (10),0.235,1
Muscle contraction,Reactome,1,C00080,10 (10),0.235,1
TP53 Regulates Transcription of Cell Death Genes,Reactome,1,C00080,10 (10),0.235,1
D-galactose degradation V (Leloir pathway),HumanCyc,1,C00080,10 (11),0.235,1
mineralocorticoid biosynthesis,HumanCyc,1,C00080,10 (10),0.235,1
PTEN Regulation,Reactome,1,C00153,10 (11),0.235,1
Erythrocytes take up carbon dioxide and release oxygen,Reactome,1,C00080,10 (11),0.235,1
phenylethylamine degradation I,HumanCyc,1,C00080,10 (10),0.235,1
Cholesterol biosynthesis via desmosterol,Reactome,1,C00080,10 (10),0.235,1
ascorbate recycling (cytosolic),HumanCyc,1,C00080,10 (10),0.235,1
Cholesterol biosynthesis via lathosterol,Reactome,1,C00080,10 (10),0.235,1
Degradation of Superoxides,SMPDB,1,C00080,10 (10),0.235,1
palmitate biosynthesis,HumanCyc,1,C00080,10 (10),0.235,1
Doxepin Metabolism Pathway,SMPDB,1,C00080,10 (10),0.235,1
Celecoxib Metabolism Pathway,SMPDB,1,C00080,10 (11),0.235,1
3-oxo-10R-octadecatrienoate beta-oxidation,EHMN,1,C00080,10 (10),0.235,1
Dimethyl-branched-chain fatty acid mitochondrial beta-oxidation,EHMN,1,C00080,10 (10),0.235,1
Trihydroxycoprostanoyl-CoA beta-oxidation,EHMN,1,C00080,10 (10),0.235,1
Vitamin B12 (cyanocobalamin) metabolism,EHMN,1,C00080,10 (10),0.235,1
Erythrocytes take up carbon dioxide and release oxygen,Wikipathways,1,C00080,10 (11),0.235,1
Amyotrophic lateral sclerosis (ALS),Wikipathways,1,C00025,10 (11),0.235,1
HIF1A and PPARG regulation of glycolysis,Wikipathways,1,C00022,10 (10),0.235,1
Differentiation Pathway,Wikipathways,1,C00153,10 (13),0.235,1
Vitamin D (calciferol) metabolism,Wikipathways,1,C00080,10 (10),0.235,1
TP53 Regulates Transcription of Cell Death Genes,Wikipathways,1,C00080,10 (10),0.235,1
Cannabinoid receptor signaling,Wikipathways,1,C00025,10 (20),0.235,1
PTEN Regulation,Wikipathways,1,C00153,10 (11),0.235,1
molybdenum cofactor biosynthesis,HumanCyc,1,C00080,10 (13),0.235,1
Pentose phosphate pathway - Homo sapiens (human),KEGG,2,C00022;C00258,35 (35),0.236,1
Pathways in cancer - Homo sapiens (human),KEGG,2,C01471;C00122,35 (35),0.236,1
Phenylalanine_ tyrosine and tryptophan biosynthesis - Homo sapiens (human),KEGG,2,C00074;C02637,35 (35),0.236,1
Inflammatory mediator regulation of TRP channels - Homo sapiens (human),KEGG,2,C00388;C00080,36 (36),0.246,1
Glycerolipid metabolism - Homo sapiens (human),KEGG,2,C00969;C00258,36 (36),0.246,1
Glycosaminoglycan metabolism,Wikipathways,2,C00033;C00080,36 (58),0.246,1
Signal Transduction,Reactome,8,C00077;C00163;C00388;C00033;C00022;C00153;C00025;C00080,228 (271),0.254,1
PAOs oxidise polyamines to amines,Reactome,1,C05665,11 (11),0.255,1
GDP-glucose biosynthesis II,HumanCyc,1,C00080,11 (11),0.255,1
Clomipramine Metabolism Pathway,SMPDB,1,C00080,11 (11),0.255,1
sucrose degradation,HumanCyc,1,C00080,11 (13),0.255,1
Interconversion of 2-oxoglutarate and 2-hydroxyglutarate,Reactome,1,C00232,11 (11),0.255,1
Eicosanoids,Reactome,1,C00080,11 (13),0.255,1
Vitamins,Reactome,1,C00080,11 (13),0.255,1
Biosynthesis of E-series 18(S)-resolvins,Reactome,1,C00080,11 (19),0.255,1
tetrapyrrole biosynthesis,HumanCyc,1,C00080,11 (11),0.255,1
urate biosynthesis/inosine 5_-phosphate degradation,HumanCyc,1,C00080,11 (11),0.255,1
Fc epsilon RI signaling pathway - Homo sapiens (human),KEGG,1,C00388,11 (11),0.255,1
taurine biosynthesis,HumanCyc,1,C00080,11 (11),0.255,1
Sulfur relay system - Homo sapiens (human),KEGG,1,C00979,11 (11),0.255,1
Gap junction - Homo sapiens (human),KEGG,1,C00025,11 (11),0.255,1
Circadian entrainment - Homo sapiens (human),KEGG,1,C00025,11 (11),0.255,1
superpathway of D-<i>myo</i>-inositol (1_4_5)-trisphosphate metabolism,HumanCyc,1,C00080,11 (11),0.255,1
Adrenergic signaling in cardiomyocytes - Homo sapiens (human),KEGG,1,C00080,11 (11),0.255,1
Thyroid hormone signaling pathway - Homo sapiens (human),KEGG,1,C00080,11 (11),0.255,1
Folate-Alcohol and Cancer Pathway Hypotheses,Wikipathways,1,C00033,11 (12),0.255,1
1D-<i>myo</i>-inositol hexakisphosphate biosynthesis II (mammalian),HumanCyc,1,C00080,11 (11),0.255,1
purine deoxyribonucleosides salvage,HumanCyc,1,C00080,11 (11),0.255,1
Metabolism of serotonin,Reactome,1,C00080,11 (11),0.255,1
formaldehyde oxidation,HumanCyc,1,C00080,11 (11),0.255,1
The retinoid cycle in cones (daylight vision),Reactome,1,C00080,11 (11),0.255,1
Plasmalogen biosynthesis,Reactome,1,C00080,11 (12),0.255,1
superoxide radicals degradation,HumanCyc,1,C00080,11 (11),0.255,1
glycine betaine degradation,HumanCyc,1,C00065,11 (11),0.255,1
Activation of NMDA receptor and postsynaptic events,Reactome,1,C00025,11 (11),0.255,1
tetrahydrobiopterin <i>de novo</i> biosynthesis,HumanCyc,1,C00080,11 (11),0.255,1
Ibuprofen Metabolism Pathway,SMPDB,1,C00080,11 (11),0.255,1
epoxysqualene biosynthesis,HumanCyc,1,C00080,11 (11),0.255,1
Imipramine Metabolism Pathway,SMPDB,1,C00080,11 (11),0.255,1
Vitamin B1 (thiamin) metabolism,EHMN,1,C00080,11 (11),0.255,1
Vitamin H (biotin) metabolism,EHMN,1,C00080,11 (11),0.255,1
Effects of PIP2 hydrolysis,Wikipathways,1,C00080,11 (13),0.255,1
biotin-carboxyl carrier protein assembly,HumanCyc,1,C00080,11 (11),0.255,1
heme biosynthesis from uroporphyrinogen-III I,HumanCyc,1,C00080,11 (11),0.255,1
TCF dependent signaling in response to WNT,Reactome,1,C00153,11 (11),0.255,1
TCF dependent signaling in response to WNT,Wikipathways,1,C00153,11 (12),0.255,1
Wax biosynthesis,Reactome,1,C00080,11 (12),0.255,1
Plasmalogen biosynthesis,Wikipathways,1,C00080,11 (12),0.255,1
glutaryl-CoA degradation,HumanCyc,1,C00080,12 (12),0.275,1
Stimuli-sensing channels,Reactome,1,C00080,12 (13),0.275,1
FMO oxidises nucleophiles,Reactome,1,C00080,12 (13),0.275,1
HS-GAG degradation,Reactome,1,C00049,12 (23),0.275,1
Reproduction,Reactome,1,C00080,12 (12),0.275,1
Methionine salvage pathway,Reactome,1,C00080,12 (19),0.275,1
Fatty acids,Reactome,1,C00080,12 (14),0.275,1
Miscellaneous substrates,Reactome,1,C00080,12 (15),0.275,1
guanosine nucleotides degradation,HumanCyc,1,C00080,12 (12),0.275,1
Cholinergic synapse - Homo sapiens (human),KEGG,1,C00033,12 (12),0.275,1
heme degradation,HumanCyc,1,C00080,12 (12),0.275,1
Effects of PIP2 hydrolysis,Reactome,1,C00080,12 (13),0.275,1
RHO GTPases Activate NADPH Oxidases,Reactome,1,C00080,12 (12),0.275,1
adenine and adenosine salvage III,HumanCyc,1,C00080,12 (12),0.275,1
spermine and spermidine degradation I,HumanCyc,1,C00080,12 (13),0.275,1
D-glucuronate degradation,HumanCyc,1,C00080,12 (12),0.275,1
phytol degradation,HumanCyc,1,C00080,12 (14),0.275,1
Tramadol Metabolism Pathway,SMPDB,1,C00080,12 (12),0.275,1
Lipoate metabolism,EHMN,1,C00080,12 (12),0.275,1
Mono-unsaturated fatty acid beta-oxidation,EHMN,1,C00080,12 (12),0.275,1
Vitamin D3 (cholecalciferol) metabolism,EHMN,1,C00080,12 (12),0.275,1
Electron Transport Chain (OXPHOS system in mitochondria),Wikipathways,1,C00080,12 (12),0.275,1
Mitochondrial biogenesis,Wikipathways,1,C00153,12 (14),0.275,1
RHO GTPases Activate NADPH Oxidases,Wikipathways,1,C00080,12 (12),0.275,1
DNA Double Strand Break Response,Wikipathways,1,C00080,12 (14),0.275,1
Synthesis of wybutosine at G37 of tRNA(Phe),Wikipathways,1,C00022,12 (14),0.275,1
NAD+ biosynthetic pathways,Wikipathways,1,C00153,12 (13),0.275,1
NO-cGMP-PKG mediated Neuroprotection,Wikipathways,1,C00025,12 (16),0.275,1
Peroxisomal lipid metabolism,Reactome,2,C00033;C00080,39 (60),0.276,1
Vitamin digestion and absorption - Homo sapiens (human),KEGG,2,C00153;C00080,39 (39),0.276,1
Purine metabolism,Wikipathways,2,C05512;C00025,39 (42),0.276,1
Peroxisomal lipid metabolism,Wikipathways,2,C00033;C00080,40 (61),0.286,1
Synthesis of wybutosine at G37 of tRNA(Phe),Reactome,1,C00022,13 (15),0.294,1
Synthesis of Lipoxins (LX),Wikipathways,1,C00080,13 (18),0.294,1
UDP-<i>N</i>-acetyl-D-galactosamine biosynthesis II,HumanCyc,1,C00080,13 (16),0.294,1
tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde,HumanCyc,1,C00080,13 (13),0.294,1
DNA Double-Strand Break Repair,Reactome,1,C00153,13 (14),0.294,1
Synthesis of 5-eicosatetraenoic acids,Reactome,1,C00080,13 (15),0.294,1
Signaling by Insulin receptor,Reactome,1,C00080,13 (13),0.294,1
Interconversion of polyamines,Reactome,1,C05665,13 (13),0.294,1
Beta oxidation of myristoyl-CoA to lauroyl-CoA,Reactome,1,C00080,13 (13),0.294,1
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA,Reactome,1,C00080,13 (13),0.294,1
Beta oxidation of octanoyl-CoA to hexanoyl-CoA,Reactome,1,C00080,13 (13),0.294,1
Beta oxidation of hexanoyl-CoA to butanoyl-CoA,Reactome,1,C00080,13 (13),0.294,1
Respiratory electron transport,Reactome,1,C00080,13 (15),0.294,1
Synthesis of Lipoxins (LX),Reactome,1,C00080,13 (18),0.294,1
adenosine nucleotides degradation,HumanCyc,1,C00080,13 (13),0.294,1
Insulin secretion - Homo sapiens (human),KEGG,1,C00022,13 (13),0.294,1
Glucocorticoid biosynthesis,Reactome,1,C00080,13 (14),0.294,1
Phospholipase D signaling pathway - Homo sapiens (human),KEGG,1,C00025,13 (13),0.294,1
GDP-fucose biosynthesis,Reactome,1,C00080,13 (15),0.294,1
estradiol biosynthesis I,HumanCyc,1,C00080,13 (13),0.294,1
Beta oxidation of palmitoyl-CoA to myristoyl-CoA,Reactome,1,C00080,13 (13),0.294,1
Serotonin clearance from the synaptic cleft,Reactome,1,C00080,13 (13),0.294,1
Regulation of TP53 Activity,Reactome,1,C00033,13 (13),0.294,1
Fc Epsilon Receptor I Signaling in Mast Cells,SMPDB,1,C00388,13 (13),0.294,1
Vitamin K Metabolism,SMPDB,1,C00163,13 (13),0.294,1
Thyroid hormone synthesis,SMPDB,1,C02218,13 (13),0.294,1
Nevirapine Metabolism Pathway,SMPDB,1,C00080,13 (13),0.294,1
Succinyl CoA: 3-ketoacid CoA transferase deficiency,SMPDB,1,C00164,13 (13),0.294,1
Ketone Body Metabolism,SMPDB,1,C00164,13 (13),0.294,1
Vitamin C metabolism,EHMN,1,C00080,13 (13),0.294,1
CDP-diacylglycerol biosynthesis,HumanCyc,1,C00080,13 (19),0.294,1
ubiquinol-10 biosynthesis,HumanCyc,1,C00080,13 (21),0.294,1
coenzyme A biosynthesis,HumanCyc,1,C00080,13 (13),0.294,1
Organelle biogenesis and maintenance,Reactome,1,C00153,13 (14),0.294,1
Cholesterol biosynthesis,Reactome,2,C00418;C00080,41 (46),0.295,1
Nucleobase biosynthesis,Wikipathways,2,C00087;C00080,41 (47),0.295,1
Cellular responses to stress,Reactome,2,C00153;C00080,42 (48),0.305,1
Class C/3 (Metabotropic glutamate/pheromone receptors),Reactome,2,C00077;C00025,42 (54),0.305,1
Squalene and cholesterol biosynthesis,EHMN,2,C00418;C00080,42 (42),0.305,1
Cholesterol biosynthesis,Wikipathways,2,C00418;C00080,42 (47),0.305,1
GPCR downstream signalling,Reactome,6,C00077;C00163;C00388;C00033;C00025;C00080,173 (209),0.307,1
Glucuronidation,Wikipathways,1,C00080,14 (14),0.313,1
eicosapentaenoate biosynthesis,HumanCyc,1,C00080,14 (17),0.313,1
Ion transport by P-type ATPases,Reactome,1,C00080,14 (17),0.313,1
Conjugation of carboxylic acids,Reactome,1,C00064,14 (15),0.313,1
Amino Acid conjugation,Reactome,1,C00064,14 (15),0.313,1
Sulfide oxidation to sulfate,Reactome,1,C00080,14 (15),0.313,1
Regulation of pyruvate dehydrogenase (PDH) complex,Reactome,1,C00022,14 (14),0.313,1
Beta oxidation of butanoyl-CoA to acetyl-CoA,Reactome,1,C00080,14 (14),0.313,1
nicotine degradation IV,HumanCyc,1,C00080,14 (28),0.313,1
Hepatocellular carcinoma - Homo sapiens (human),KEGG,1,C01471,14 (14),0.313,1
Mineralocorticoid biosynthesis,Reactome,1,C00080,14 (15),0.313,1
Molybdenum cofactor biosynthesis,Reactome,1,C00080,14 (20),0.313,1
Axon guidance,Reactome,1,C00025,14 (15),0.313,1
purine ribonucleosides degradation to ribose-1-phosphate,HumanCyc,1,C00080,14 (15),0.313,1
androgen biosynthesis,HumanCyc,1,C00080,14 (15),0.313,1
Phenylalanine degradation,INOH,1,C00025,14 (14),0.313,1
pentose phosphate pathway,HumanCyc,1,C00080,14 (16),0.313,1
Heroin Action Pathway,SMPDB,1,C00033,14 (14),0.313,1
pyridoxal 5_-phosphate salvage,HumanCyc,1,C00080,14 (14),0.313,1
Vitamin B2 (riboflavin) metabolism,EHMN,1,C00080,14 (14),0.313,1
Cholesterol Biosynthesis Pathway,Wikipathways,1,C00418,14 (14),0.313,1
ROS_ RNS production in phagocytes,Wikipathways,1,C00080,14 (19),0.313,1
Wax biosynthesis,Wikipathways,1,C00080,14 (15),0.313,1
Formation of xylulose-5-phosphate,Wikipathways,1,C00080,14 (16),0.313,1
superpathway of cholesterol biosynthesis,HumanCyc,2,C00418;C00080,43 (62),0.315,1
Signaling by GPCR,Reactome,6,C00077;C00163;C00388;C00033;C00025;C00080,176 (213),0.321,1
Infectious disease,Reactome,2,C00153;C00080,44 (55),0.325,1
Thiamine metabolic pathways,Wikipathways,1,C00022,15 (21),0.331,1
Biosynthesis of EPA-derived SPMs,Wikipathways,1,C00080,15 (27),0.331,1
serotonin degradation,HumanCyc,1,C00080,15 (20),0.331,1
Toll-Like Receptors Cascades,Reactome,1,C00080,15 (29),0.331,1
Synthesis of 15-eicosatetraenoic acid derivatives,Reactome,1,C00080,15 (16),0.331,1
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),Reactome,1,C00080,15 (15),0.331,1
Serotonin and melatonin biosynthesis,Reactome,1,C00080,15 (15),0.331,1
Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA,Reactome,1,C00080,15 (15),0.331,1
Chromatin modifying enzymes,Reactome,1,C00033,15 (16),0.331,1
Biosynthesis of EPA-derived SPMs,Reactome,1,C00080,15 (27),0.331,1
tryptophan degradation X (mammalian_ via tryptamine),HumanCyc,1,C00080,15 (15),0.331,1
HIF-1 signaling pathway - Homo sapiens (human),KEGG,1,C00022,15 (15),0.331,1
Ubiquinol biosynthesis,Reactome,1,C00080,15 (22),0.331,1
Antigen processing-Cross presentation,Reactome,1,C00080,15 (18),0.331,1
Chromatin organization,Reactome,1,C00033,15 (16),0.331,1
serotonin and melatonin biosynthesis,HumanCyc,1,C00080,15 (15),0.331,1
Sphingolipid pathway,Wikipathways,1,C00065,15 (16),0.331,1
Catabolism of glucuronate to xylulose-5-phosphate,Reactome,1,C00080,15 (16),0.331,1
Melanin biosynthesis,Wikipathways,1,C00080,15 (23),0.331,1
Chromatin organization,Wikipathways,1,C00033,15 (16),0.331,1
Terpenoid backbone biosynthesis - Homo sapiens (human),KEGG,2,C00022;C00418,45 (45),0.335,1
Biosynthesis of DHA-derived SPMs,Wikipathways,1,C00080,16 (72),0.349,1
Heme Biosynthesis,Wikipathways,1,C00080,16 (16),0.349,1
RA biosynthesis pathway,Reactome,1,C00080,16 (17),0.349,1
Synthesis of glycosylphosphatidylinositol (GPI),Reactome,1,C00033,16 (18),0.349,1
zymosterol biosynthesis,HumanCyc,1,C00080,16 (22),0.349,1
Selenocysteine synthesis,Reactome,1,C00080,16 (20),0.349,1
CYP2E1 reactions,Reactome,1,C00080,16 (19),0.349,1
Antimicrobial peptides,Reactome,1,C00080,16 (23),0.349,1
Abacavir metabolism,Reactome,1,C00080,16 (23),0.349,1
Synthesis of bile acids and bile salts via 27-hydroxycholesterol,Reactome,1,C00080,16 (18),0.349,1
Sphingolipid signaling pathway - Homo sapiens (human),KEGG,1,C00065,16 (16),0.349,1
Tolerance by Mtb to nitric oxide produced by macrophages,Reactome,1,C00080,16 (22),0.349,1
Porphyrin metabolism,INOH,1,C00080,16 (16),0.349,1
catecholamine biosynthesis,HumanCyc,1,C00080,16 (16),0.349,1
Desipramine Action Pathway,SMPDB,1,C00080,16 (16),0.349,1
Omega-3 fatty acid metabolism,EHMN,1,C00080,16 (16),0.349,1
Vitamin B6 (pyridoxine) metabolism,EHMN,1,C00080,16 (16),0.349,1
Ubiquinol biosynthesis,Wikipathways,1,C00080,16 (24),0.349,1
Kennedy pathway from Sphingolipids,Wikipathways,1,C00065,16 (18),0.349,1
Ascorbate and aldarate metabolism - Homo sapiens (human),KEGG,2,C00022;C00433,48 (48),0.364,1
stearate biosynthesis,HumanCyc,1,C00080,17 (17),0.366,1
pyrimidine deoxyribonucleotides biosynthesis from CTP,HumanCyc,1,C00080,17 (17),0.366,1
Catecholamine biosynthesis,Reactome,1,C00080,17 (18),0.366,1
Vitamin B6 metabolism,INOH,1,C00025,17 (17),0.366,1
Thyroxine biosynthesis,Reactome,1,C00080,17 (17),0.366,1
ROS_ RNS production in phagocytes,Reactome,1,C00080,17 (21),0.366,1
Abacavir transport and metabolism,Reactome,1,C00080,17 (24),0.366,1
Melanin biosynthesis,Reactome,1,C00080,17 (23),0.366,1
Synthesis of bile acids and bile salts via 24-hydroxycholesterol,Reactome,1,C00080,17 (29),0.366,1
Salivary secretion - Homo sapiens (human),KEGG,1,C00080,17 (17),0.366,1
Pancreatic secretion - Homo sapiens (human),KEGG,1,C00080,17 (17),0.366,1
Androgen biosynthesis,Reactome,1,C00080,17 (17),0.366,1
dopamine degradation,HumanCyc,1,C00080,17 (17),0.366,1
fatty acid &alpha;-oxidation III,HumanCyc,1,C00080,17 (22),0.366,1
Lidocaine (Local Anaesthetic) Metabolism Pathway,SMPDB,1,C00080,17 (17),0.366,1
Post-translational modification- synthesis of GPI-anchored proteins,Wikipathways,1,C00033,17 (21),0.366,1
Abacavir transport and metabolism,Wikipathways,1,C00080,17 (24),0.366,1
fatty acid &alpha;-oxidation,HumanCyc,1,C00080,17 (20),0.366,1
Nucleotide Metabolism,Wikipathways,1,C00077,17 (18),0.366,1
Antimicrobial peptides,Wikipathways,1,C00080,17 (25),0.366,1
Phosphatidylinositol phosphate metabolism,EHMN,2,C00033;C00080,49 (49),0.373,1
Cellular responses to external stimuli,Reactome,2,C00153;C00080,50 (57),0.383,1
Amine Oxidase reactions,Reactome,1,C05665,18 (18),0.383,1
Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,Reactome,1,C00080,18 (18),0.383,1
Beta-oxidation of very long chain fatty acids,Reactome,1,C00080,18 (26),0.383,1
heme biosynthesis,HumanCyc,1,C00080,18 (18),0.383,1
RAF/MAP kinase cascade,Reactome,1,C00025,18 (18),0.383,1
MAPK1/MAPK3 signaling,Reactome,1,C00025,18 (18),0.383,1
MAPK family signaling cascades,Reactome,1,C00025,18 (18),0.383,1
Synthesis of IP2_ IP_ and Ins in the cytosol,Reactome,1,C00080,18 (18),0.383,1
superpathway of inositol phosphate compounds,HumanCyc,1,C00080,18 (26),0.383,1
Nicotine Metabolism Pathway,SMPDB,1,C00080,18 (21),0.383,1
Felbamate Metabolism Pathway,SMPDB,1,C00080,18 (18),0.383,1
Cori Cycle,Wikipathways,1,C00022,18 (24),0.383,1
Iron uptake and transport,Wikipathways,1,C00080,18 (20),0.383,1
Iron uptake and transport,Reactome,1,C00080,19 (21),0.399,1
Post-translational modification: synthesis of GPI-anchored proteins,Reactome,1,C00033,19 (21),0.399,1
Tamoxifen Metabolism Pathway,SMPDB,1,C00080,19 (20),0.399,1
purine nucleotides degradation,HumanCyc,1,C00080,19 (19),0.399,1
Retrograde endocannabinoid signaling - Homo sapiens (human),KEGG,1,C00025,19 (19),0.399,1
pyrimidine deoxyribonucleotides <i>de novo</i> biosynthesis,HumanCyc,1,C00080,19 (19),0.399,1
Neurotransmitter receptors and postsynaptic signal transmission,Reactome,1,C00025,19 (19),0.399,1
Tamoxifen Action Pathway,SMPDB,1,C00080,19 (20),0.399,1
Carbamazepine Metabolism Pathway,SMPDB,1,C00080,19 (19),0.399,1
Ubiquinone Biosynthesis,SMPDB,1,C00080,19 (19),0.399,1
Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids,SMPDB,1,C00080,19 (19),0.399,1
Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD),SMPDB,1,C00080,19 (19),0.399,1
Butyrate Metabolism,SMPDB,1,C00164,19 (19),0.399,1
Di-unsaturated fatty acid beta-oxidation,EHMN,1,C00080,19 (19),0.399,1
Metabolism of folate and pterines,Wikipathways,1,C00080,19 (26),0.399,1
Ion channel transport,Wikipathways,1,C00080,19 (23),0.399,1
Phase I - Functionalization of compounds,Wikipathways,5,C00033;C05665;C05130;C00080;C00388,157 (195),0.401,1
Phase I - Functionalization of compounds,Reactome,5,C00033;C05665;C05130;C00080;C00388,159 (193),0.412,1
Epigenetic regulation of gene expression,Reactome,1,C00153,20 (24),0.415,1
Ion channel transport,Reactome,1,C00080,20 (24),0.415,1
noradrenaline and adrenaline degradation,HumanCyc,1,C00080,20 (20),0.415,1
PIP3 activates AKT signaling,Reactome,1,C00153,20 (22),0.415,1
Phenytoin (Antiarrhythmic) Action Pathway,SMPDB,1,C00080,20 (21),0.415,1
Imipramine Action Pathway,SMPDB,1,C00080,20 (20),0.415,1
Hypophosphatasia,SMPDB,1,C00266,20 (20),0.415,1
Vitamin B6 Metabolism,SMPDB,1,C00266,20 (20),0.415,1
Respiratory electron transport_ ATP synthesis by chemiosmotic coupling_ and heat production by uncoupling proteins.,Wikipathways,1,C00080,20 (22),0.415,1
Bile acid biosynthesis,EHMN,2,C00163;C00080,55 (55),0.43,1
Glycosphingolipid metabolism,EHMN,2,C00065;C00080,55 (55),0.43,1
Detoxification of Reactive Oxygen Species,Reactome,1,C00080,21 (24),0.431,1
Respiratory electron transport_ ATP synthesis by chemiosmotic coupling_ and heat production by uncoupling proteins.,Reactome,1,C00080,21 (23),0.431,1
Insulin resistance - Homo sapiens (human),KEGG,1,C00022,21 (21),0.431,1
Class I MHC mediated antigen processing & presentation,Reactome,1,C00080,21 (24),0.431,1
The canonical retinoid cycle in rods (twilight vision),Reactome,1,C00080,21 (33),0.431,1
cholesterol biosynthesis II (via 24_25-dihydrolanosterol),HumanCyc,1,C00080,21 (32),0.431,1
Vitamin B5 - CoA biosynthesis from pantothenate,EHMN,1,C00080,21 (21),0.431,1
Vitamin E metabolism,EHMN,1,C00080,21 (21),0.431,1
Gamma carboxylation_ hypusine formation and arylsulfatase activation,Wikipathways,1,C00080,21 (30),0.431,1
TP53 Regulates Metabolic Genes,Wikipathways,1,C00080,21 (25),0.431,1
Class I MHC mediated antigen processing & presentation,Wikipathways,1,C00080,21 (24),0.431,1
Tetrahydrobiopterin (BH4) synthesis_ recycling_ salvage and regulation,Wikipathways,1,C00080,22 (27),0.446,1
Synthesis of very long-chain fatty acyl-CoAs,Reactome,1,C00080,22 (27),0.446,1
Alpha-oxidation of phytanate,Reactome,1,C00080,22 (25),0.446,1
Familial lipoprotein lipase deficiency,SMPDB,1,C00258,22 (24),0.446,1
Glycerolipid Metabolism,SMPDB,1,C00258,22 (24),0.446,1
Glycerol Kinase Deficiency,SMPDB,1,C00258,22 (24),0.446,1
D-glyceric acidura,SMPDB,1,C00258,22 (24),0.446,1
Phytanic acid peroxisomal oxidation,EHMN,1,C00080,22 (22),0.446,1
Xenobiotics metabolism,EHMN,3,C14855;C14856;C00080,93 (93),0.448,1
retinol biosynthesis,HumanCyc,1,C00080,23 (37),0.461,1
TCA Cycle (aka Krebs or citric acid cycle),Wikipathways,1,C00122,23 (24),0.461,1
Glucuronidation,Reactome,1,C00080,23 (31),0.461,1
arsenate detoxification I (glutaredoxin),HumanCyc,1,C00080,23 (24),0.461,1
Synthesis of PC,Reactome,1,C00033,23 (28),0.461,1
AMPK signaling pathway - Homo sapiens (human),KEGG,1,C00022,23 (23),0.461,1
Glycosphingolipid biosynthesis - globoseries,EHMN,1,C00080,23 (23),0.461,1
Omega-6 fatty acid metabolism,EHMN,1,C00080,23 (23),0.461,1
Metabolism of nitric oxide,Wikipathways,1,C00080,23 (26),0.461,1
Detoxification of Reactive Oxygen Species,Wikipathways,1,C00080,23 (26),0.461,1
Transport of vitamins_ nucleosides_ and related molecules,Wikipathways,2,C00475;C00178,60 (60),0.474,1
Ferroptosis,Wikipathways,1,C00418,24 (29),0.475,1
Thermogenesis,Wikipathways,1,C00080,24 (25),0.475,1
Signaling by WNT,Reactome,1,C00153,24 (25),0.475,1
Gamma carboxylation_ hypusine formation and arylsulfatase activation,Reactome,1,C00080,24 (33),0.475,1
Tetrahydrobiopterin (BH4) synthesis_ recycling_ salvage and regulation,Reactome,1,C00080,24 (27),0.475,1
cholesterol biosynthesis III (via desmosterol),HumanCyc,1,C00080,24 (32),0.475,1
Synthesis of PA,Reactome,1,C00080,24 (26),0.475,1
Mercaptopurine Metabolism Pathway,SMPDB,1,C00064,24 (24),0.475,1
Linoleate metabolism,EHMN,1,C00080,24 (24),0.475,1
Biopterin metabolism,EHMN,1,C00080,24 (24),0.475,1
Cardiac conduction,Wikipathways,1,C00080,24 (25),0.475,1
cholesterol biosynthesis I,HumanCyc,1,C00080,24 (32),0.475,1
C21-steroid hormone biosynthesis and metabolism,EHMN,2,C00033;C00080,61 (61),0.483,1
G alpha (s) signalling events,Wikipathways,1,C00388,25 (25),0.489,1
Metabolism of nitric oxide,Reactome,1,C00080,25 (26),0.489,1
eNOS activation,Reactome,1,C00080,25 (26),0.489,1
Sphingolipid metabolism - Homo sapiens (human),KEGG,1,C00065,25 (25),0.489,1
eNOS activation and regulation,Reactome,1,C00080,25 (26),0.489,1
Thermogenesis - Homo sapiens (human),KEGG,1,C00080,25 (25),0.489,1
Prostaglandin Leukotriene metabolism,INOH,1,C00025,25 (25),0.489,1
Lidocaine (Antiarrhythmic) Action Pathway,SMPDB,1,C00080,25 (25),0.489,1
Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids,SMPDB,1,C00080,25 (25),0.489,1
Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids,SMPDB,1,C00080,25 (26),0.489,1
Hemostasis,Reactome,2,C00033;C00080,63 (67),0.5,1
Heme biosynthesis,Reactome,1,C00080,26 (28),0.503,1
Cobalamin (Cbl_ vitamin B12) transport and metabolism,Reactome,1,C00080,26 (28),0.503,1
RHO GTPase Effectors,Reactome,1,C00080,26 (27),0.503,1
Signaling by Rho GTPases,Reactome,1,C00080,26 (27),0.503,1
Retinoid metabolism and transport,Reactome,1,C00080,26 (35),0.503,1
Lidocaine (Local Anaesthetic) Action Pathway,SMPDB,1,C00080,26 (26),0.503,1
sarcosine oncometabolite pathway ,SMPDB,1,C00065,26 (26),0.503,1
Signaling by VEGF,Wikipathways,1,C00080,26 (28),0.503,1
Latent infection of Homo sapiens with Mycobacterium tuberculosis,Wikipathways,1,C00080,26 (35),0.503,1
Response of Mtb to phagocytosis,Reactome,1,C00080,26 (35),0.503,1
Latent infection of Homo sapiens with Mycobacterium tuberculosis,Reactome,1,C00080,26 (35),0.503,1
Pentose phosphate pathway,Wikipathways,1,C00080,26 (31),0.503,1
Transport of vitamins_ nucleosides_ and related molecules,Reactome,2,C00475;C00178,64 (64),0.509,1
VEGFA-VEGFR2 Pathway,Reactome,1,C00080,27 (28),0.516,1
Signaling by VEGF,Reactome,1,C00080,27 (28),0.516,1
Nicotine Action Pathway,SMPDB,1,C00080,27 (30),0.516,1
Leukotriene metabolism,EHMN,1,C00080,27 (27),0.516,1
Biotin metabolism - Homo sapiens (human),KEGG,1,C01037,28 (28),0.529,1
Intracellular signaling by second messengers,Reactome,1,C00153,28 (30),0.529,1
Vitamin A (retinol) metabolism,EHMN,1,C00080,28 (28),0.529,1
Retinoid metabolism and transport,Wikipathways,1,C00080,28 (37),0.529,1
acyl-CoA hydrolysis,HumanCyc,1,C00080,29 (39),0.541,1
Metabolism of steroid hormones,Wikipathways,1,C00080,29 (35),0.541,1
Metabolism of fat-soluble vitamins,Reactome,1,C00080,30 (41),0.553,1
Glycerophospholipid biosynthesis,Wikipathways,2,C00033;C00080,70 (94),0.557,1
triacylglycerol degradation,HumanCyc,1,C00080,31 (54),0.565,1
Steroids metabolism,INOH,1,C00418,31 (31),0.565,1
Pentose phosphate pathway (hexose monophosphate shunt),Reactome,1,C00080,31 (31),0.565,1
pyrimidine deoxyribonucleosides salvage,HumanCyc,1,C00080,31 (31),0.565,1
Metabolism of steroid hormones,Reactome,1,C00080,31 (36),0.565,1
sphingomyelin metabolism/ceramide salvage,HumanCyc,1,C00080,31 (55),0.565,1
Valproic Acid Metabolism Pathway,SMPDB,1,C00080,31 (31),0.565,1
Neurotransmitter release cycle,Wikipathways,1,C00080,31 (37),0.565,1
superpathway of pyrimidine deoxyribonucleoside salvage,HumanCyc,1,C00080,31 (31),0.565,1
Disease,Reactome,2,C00153;C00080,72 (104),0.573,1
Glycerophospholipid biosynthesis,Reactome,2,C00033;C00080,72 (93),0.573,1
Phenylalanine metabolism - Homo sapiens (human),KEGG,2,C00022;C00122,72 (72),0.573,1
phospholipases,HumanCyc,1,C00080,32 (55),0.577,1
Platelet activation_ signaling and aggregation,Reactome,1,C00080,32 (33),0.577,1
Sphingolipid de novo biosynthesis,Reactome,1,C00080,32 (35),0.577,1
17-Beta Hydroxysteroid Dehydrogenase III Deficiency,SMPDB,1,C00080,32 (32),0.577,1
Androgen and Estrogen Metabolism,SMPDB,1,C00080,32 (32),0.577,1
Aromatase deficiency,SMPDB,1,C00080,32 (32),0.577,1
Methylation,Reactome,1,C00080,33 (37),0.588,1
G alpha (s) signalling events,Reactome,1,C00388,33 (33),0.588,1
superpathway of steroid hormone biosynthesis,HumanCyc,1,C00080,33 (35),0.588,1
Inositol phosphate metabolism,Wikipathways,1,C00080,33 (41),0.588,1
Celecoxib Action Pathway,SMPDB,2,C00025;C00080,75 (76),0.595,1
Fatty acyl-CoA biosynthesis,Reactome,1,C00080,34 (42),0.599,1
Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD),SMPDB,1,C00080,34 (34),0.599,1
Fatty Acid Elongation In Mitochondria,SMPDB,1,C00080,34 (34),0.599,1
Fructose and mannose metabolism,EHMN,1,C00080,34 (34),0.599,1
Metabolism of porphyrins,Wikipathways,1,C00080,34 (37),0.599,1
Amine-derived hormones,Wikipathways,1,C00080,34 (38),0.599,1
Fatty acyl-CoA biosynthesis,Wikipathways,1,C00080,34 (42),0.599,1
Ibuprofen Action Pathway,SMPDB,2,C00025;C00080,77 (77),0.609,1
Metabolism of porphyrins,Reactome,1,C00080,35 (37),0.61,1
Inositol phosphate metabolism,Reactome,1,C00080,35 (43),0.61,1
Steroid hormones,Reactome,1,C00080,35 (40),0.61,1
Phase II - Conjugation of compounds,Wikipathways,3,C14856;C01879;C00080,119 (151),0.615,1
Tryptophan metabolism,EHMN,2,C00025;C00080,78 (78),0.617,1
Endogenous sterols,Reactome,1,C00080,37 (43),0.63,1
Pentose phosphate pathway,EHMN,1,C00080,37 (37),0.63,1
Cytosolic sulfonation of small molecules,Reactome,1,C00080,37 (47),0.63,1
Metabolism of cofactors,Reactome,1,C00080,37 (47),0.63,1
Amine-derived hormones,Reactome,1,C00080,37 (38),0.63,1
Glycerophospholipid Biosynthetic Pathway,Wikipathways,1,C00065,37 (49),0.63,1
Phospholipid metabolism,Reactome,2,C00033;C00080,80 (103),0.63,1
Synthesis of Prostaglandins (PG) and Thromboxanes (TX),Reactome,1,C00080,38 (43),0.64,1
the visual cycle I (vertebrates),HumanCyc,1,C00080,38 (58),0.64,1
Glycosphingolipid biosynthesis - ganglioseries,EHMN,1,C00080,38 (38),0.64,1
sphingosine and sphingosine-1-phosphate metabolism,HumanCyc,1,C00080,39 (59),0.65,1
Adaptive Immune System,Reactome,1,C00080,39 (54),0.65,1
Sphingolipid Metabolism,SMPDB,1,C00065,39 (40),0.65,1
Gaucher Disease,SMPDB,1,C00065,39 (40),0.65,1
Globoid Cell Leukodystrophy,SMPDB,1,C00065,39 (40),0.65,1
Metachromatic Leukodystrophy (MLD),SMPDB,1,C00065,39 (40),0.65,1
Fabry disease,SMPDB,1,C00065,39 (40),0.65,1
Krabbe disease,SMPDB,1,C00065,39 (40),0.65,1
Arachidonic acid metabolism,Reactome,2,C00025;C00080,84 (104),0.657,1
Selenium Micronutrient Network,Wikipathways,2,C00065;C00153,84 (103),0.657,1
cAMP signaling pathway - Homo sapiens (human),KEGG,1,C00080,40 (40),0.659,1
G alpha (i) signalling events,Reactome,3,C00388;C00080;C00025,127 (159),0.659,1
Xenobiotics,Reactome,1,C00080,41 (52),0.668,1
Purine catabolism,Reactome,1,C05512,41 (53),0.668,1
Visual phototransduction,Wikipathways,1,C00080,41 (57),0.668,1
Neuroactive ligand-receptor interaction - Homo sapiens (human),KEGG,3,C00049;C00388;C00025,130 (130),0.675,1
mitochondrial fatty acid beta-oxidation of saturated fatty acids,Reactome,1,C00080,42 (42),0.677,1
bile acid biosynthesis_ neutral pathway,HumanCyc,1,C00080,42 (44),0.677,1
Steroidogenesis,SMPDB,1,C00080,42 (43),0.677,1
Apparent mineralocorticoid excess syndrome,SMPDB,1,C00080,42 (43),0.677,1
3-Beta-Hydroxysteroid Dehydrogenase Deficiency,SMPDB,1,C00080,42 (43),0.677,1
21-hydroxylase deficiency (CYP21),SMPDB,1,C00080,42 (43),0.677,1
Corticosterone methyl oxidase I deficiency (CMO I),SMPDB,1,C00080,42 (43),0.677,1
Corticosterone methyl oxidase II deficiency - CMO II,SMPDB,1,C00080,42 (43),0.677,1
Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency,SMPDB,1,C00080,42 (43),0.677,1
Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency,SMPDB,1,C00080,42 (43),0.677,1
Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH,SMPDB,1,C00080,42 (43),0.677,1
17-alpha-hydroxylase deficiency (CYP17),SMPDB,1,C00080,42 (43),0.677,1
Signaling by Receptor Tyrosine Kinases,Reactome,1,C00080,42 (44),0.677,1
11-beta-hydroxylase deficiency (CYP11B1),SMPDB,1,C00080,42 (43),0.677,1
Long chain acyl-CoA dehydrogenase deficiency (LCAD),SMPDB,1,C00080,43 (43),0.686,1
Trifunctional protein deficiency,SMPDB,1,C00080,43 (43),0.686,1
Carnitine palmitoyl transferase deficiency (II),SMPDB,1,C00080,43 (43),0.686,1
Very-long-chain acyl coa dehydrogenase deficiency (VLCAD),SMPDB,1,C00080,43 (43),0.686,1
Medium chain acyl-coa dehydrogenase deficiency (MCAD),SMPDB,1,C00080,43 (43),0.686,1
Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency),SMPDB,1,C00080,43 (43),0.686,1
Fatty acid Metabolism,SMPDB,1,C00080,43 (43),0.686,1
Glutaric Aciduria Type I,SMPDB,1,C00080,43 (43),0.686,1
Ethylmalonic Encephalopathy,SMPDB,1,C00080,43 (43),0.686,1
Carnitine palmitoyl transferase deficiency (I),SMPDB,1,C00080,43 (43),0.686,1
Saturated fatty acids beta-oxidation,EHMN,1,C00080,43 (43),0.686,1
tRNA modification in the nucleus and cytosol,Reactome,1,C00022,44 (47),0.694,1
Interconversion of nucleotide di- and triphosphates,Wikipathways,1,C00080,44 (51),0.694,1
Hyper-IgD syndrome,SMPDB,1,C00418,45 (45),0.702,1
Cholesteryl ester storage disease,SMPDB,1,C00418,45 (45),0.702,1
Lysosomal Acid Lipase Deficiency (Wolman Disease),SMPDB,1,C00418,45 (45),0.702,1
Mevalonic aciduria,SMPDB,1,C00418,45 (45),0.702,1
Wolman disease,SMPDB,1,C00418,45 (45),0.702,1
Smith-Lemli-Opitz Syndrome (SLOS),SMPDB,1,C00418,45 (45),0.702,1
Chondrodysplasia Punctata II_ X Linked Dominant (CDPX2),SMPDB,1,C00418,45 (45),0.702,1
CHILD Syndrome,SMPDB,1,C00418,45 (45),0.702,1
Desmosterolosis,SMPDB,1,C00418,45 (45),0.702,1
Hypercholesterolemia,SMPDB,1,C00418,45 (45),0.702,1
Steroid Biosynthesis,SMPDB,1,C00418,45 (45),0.702,1
Ibandronate Action Pathway,SMPDB,1,C00418,45 (45),0.702,1
Simvastatin Action Pathway,SMPDB,1,C00418,46 (46),0.71,1
Pravastatin Action Pathway,SMPDB,1,C00418,46 (46),0.71,1
Atorvastatin Action Pathway,SMPDB,1,C00418,46 (46),0.71,1
Alendronate Action Pathway,SMPDB,1,C00418,46 (46),0.71,1
Rosuvastatin Action Pathway,SMPDB,1,C00418,46 (46),0.71,1
Lovastatin Action Pathway,SMPDB,1,C00418,46 (46),0.71,1
Risedronate Action Pathway,SMPDB,1,C00418,46 (46),0.71,1
Cerivastatin Action Pathway,SMPDB,1,C00418,46 (46),0.71,1
Pamidronate Action Pathway,SMPDB,1,C00418,46 (46),0.71,1
Fluvastatin Action Pathway,SMPDB,1,C00418,46 (46),0.71,1
Zoledronate Action Pathway,SMPDB,1,C00418,46 (46),0.71,1
Vitamin B12 Metabolism,Wikipathways,1,C00065,46 (60),0.71,1
tRNA processing,Reactome,1,C00022,47 (51),0.718,1
Purine metabolism - Homo sapiens (human),KEGG,2,C00064;C05512,95 (95),0.722,1
Galactose metabolism,EHMN,1,C00080,48 (48),0.725,1
Prostaglandin formation from arachidonate,EHMN,1,C00080,48 (48),0.725,1
Porphyrin metabolism,EHMN,1,C00080,48 (48),0.725,1
Porphyrin and chlorophyll metabolism - Homo sapiens (human),KEGG,3,C02800;C00025;C00188,141 (141),0.728,1
Visual phototransduction,Reactome,1,C00080,49 (65),0.733,1
Chemical carcinogenesis - Homo sapiens (human),KEGG,2,C14855;C14856,99 (99),0.743,1
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,Reactome,1,C00080,51 (51),0.747,1
Folate Metabolism,Wikipathways,1,C00065,51 (66),0.747,1
Drug metabolism - other enzymes - Homo sapiens (human),KEGG,1,C16633,52 (52),0.754,1
Arachidonic acid metabolism,EHMN,1,C00080,53 (53),0.76,1
Fructose and mannose metabolism - Homo sapiens (human),KEGG,1,C00424,54 (54),0.767,1
Metabolism of RNA,Reactome,1,C00022,56 (72),0.779,1
Folate biosynthesis - Homo sapiens (human),KEGG,1,C00266,57 (57),0.785,1
Mitochondrial Fatty Acid Beta-Oxidation,Reactome,1,C00080,58 (66),0.791,1
Tryptophan Metabolism,SMPDB,1,C00025,59 (60),0.796,1
De novo fatty acid biosynthesis,EHMN,1,C00080,59 (59),0.796,1
Sphingolipid metabolism,Wikipathways,1,C00080,59 (67),0.796,1
Mitochondrial Fatty Acid Beta-Oxidation,Wikipathways,1,C00080,59 (67),0.796,1
fatty acid &beta;-oxidation,HumanCyc,1,C00080,60 (84),0.802,1
Bile acid and bile salt metabolism,Wikipathways,1,C00080,60 (76),0.802,1
Synthesis of bile acids and bile salts,Reactome,1,C00080,61 (75),0.807,1
fatty acid &beta;-oxidation (peroxisome),HumanCyc,1,C00080,61 (85),0.807,1
Sphingolipid metabolism,Reactome,1,C00080,62 (68),0.812,1
Androgen and estrogen biosynthesis and metabolism,EHMN,1,C00080,62 (62),0.812,1
glutathione redox reactions I,HumanCyc,1,C00080,64 (100),0.822,1
Bile acid and bile salt metabolism,Reactome,1,C00080,66 (80),0.832,1
Metabolism of steroids,Reactome,2,C00418;C00080,120 (144),0.833,1
Metabolism of water-soluble vitamins and cofactors,Wikipathways,1,C00080,67 (79),0.836,1
Innate Immune System,Reactome,1,C00080,67 (99),0.836,1
Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human),KEGG,2,C14855;C14856,121 (121),0.836,1
Leukotriene C4 Synthesis Deficiency,SMPDB,1,C00025,71 (71),0.853,1
Antrafenine Action Pathway,SMPDB,1,C00025,71 (71),0.853,1
Trisalicylate-choline Action Pathway,SMPDB,1,C00025,71 (71),0.853,1
Lornoxicam Action Pathway,SMPDB,1,C00025,71 (71),0.853,1
Tenoxicam Action Pathway,SMPDB,1,C00025,71 (71),0.853,1
Arachidonic Acid Metabolism,SMPDB,1,C00025,71 (71),0.853,1
Etodolac Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Ketoprofen Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Rofecoxib Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Acetylsalicylic Acid Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Diflunisal Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Sulindac Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Diclofenac Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Ketorolac Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Naproxen Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Etoricoxib Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Carprofen Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Flurbiprofen Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Fenoprofen Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Antipyrine Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Lumiracoxib Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Magnesium salicylate Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Nepafenac Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Phenylbutazone Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Salsalate Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Tiaprofenic Acid Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Tolmetin Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Salicylic Acid Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Salicylate-sodium Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Oxaprozin Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Valdecoxib Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Nabumetone Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Indomethacin Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Meloxicam Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Suprofen Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Bromfenac Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Mefenamic Acid Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Piroxicam Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
Acetaminophen  Action Pathway,SMPDB,1,C00025,72 (72),0.857,1
G alpha (i) signalling events,Wikipathways,1,C00388,75 (93),0.868,1
Neomycin_ kanamycin and gentamicin biosynthesis - Homo sapiens (human),KEGG,1,C00025,81 (81),0.888,1
Tryptophan metabolism - Homo sapiens (human),KEGG,1,C02220,81 (81),0.888,1
Asparagine N-linked glycosylation,Wikipathways,1,C00080,84 (101),0.897,1
Arachidonic acid metabolism,Wikipathways,1,C00080,84 (107),0.897,1
Fatty acid metabolism,Reactome,3,C00033;C00025;C00080,199 (367),0.904,1
Drug metabolism - cytochrome P450 - Homo sapiens (human),KEGG,1,C01471,88 (88),0.908,1
Immune System,Reactome,1,C00080,91 (136),0.915,1
Cytochrome P450 - arranged by substrate type,Reactome,1,C00080,95 (121),0.924,1
chondroitin sulfate degradation (metazoa),HumanCyc,1,C00080,100 (134),0.933,1
dermatan sulfate degradation (metazoa),HumanCyc,1,C00080,101 (135),0.935,1
Metabolism of lipids,Reactome,5,C00033;C00418;C00164;C00080;C00025,398 (620),0.984,1
Bile secretion - Homo sapiens (human),KEGG,1,C00080,162 (162),0.988,1